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CHAPTER I 
 
INTRODUCTION 
 
Linear eukaryotic chromosome ends are capped by telomeres, protein-DNA 
complexes that protect the chromosome from nucleolytic degradation and random 
fusions1. In most eukaryotes, telomeres are composed of repetitive G-rich DNA 
sequences that are maintained by a ribonucleoprotein complex named telomerase. In S. 
cerevisiae, telomeric repeats are irregular TG1-3 repeats while in most higher eukaryotes 
the repeats are perfect hexanucleotides (for example, TTAGGG in human). Telomere 
length is regulated at multiple levels, including telomerase assembly, telomerase 
recruitment and telomere accessibility. Besides telomerase, Rap1p in S. cerevisiae and its 
mammalian orthologues Taz1 and TRF1 are major regulators of telomere length2-4. This 
dissertation describes experiments to investigate the mechanism through which several 
mutations in the telomerase catalytic subunit (Est2p) cause over-elongated telomeres.  In 
this process, a novel role of Est2p in regulating template usage and telomere length 
indirectly through Rap1p is uncovered. 
 
End Replication Problem and Telomerase 
Because of the nature of DNA polymerase, semiconservative DNA replication 
results in loss of terminal DNA sequences with cell division, a phenomenon originally 
proposed by James Watson and Alexey Olovnikov in the early 1970s and known as the 
“end replication problem.” All known DNA polymerases require a polynucleotide primer 
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(either DNA or RNA) with a 3’-hydroxyl (3’-OH) group to initiate synthesis in the 5'-3' 
direction. At the end of a linear chromosome, DNA polymerase can synthesize the 
leading strand until the end of the chromosome. On the lagging strand, however, DNA 
polymerase's synthesis is based on a series of fragments, called Okazaki, each requiring 
an RNA primer. Without DNA to serve as template for a new primer, the replication 
machinery is unable to synthesize the sequence complementary to the final RNA primer. 
The result is the "end-replication problem" in which sequence is lost at each round of 
DNA replication (Figure 1; ref. 5, 6). This phenomenon has been shown to occur in vitro, 
and it is supported by the observation that telomeres shorten over successive cell 
divisions 7, 8. Without a solution, DNA sequences continue to shorten and cells enter 
replicative senescence.  
Telomeres and telomerase have been proposed to solve the end replication 
problem. First discovered in Tetrahymena in 19859, telomerase, a ribonucleoprotein that 
contains a reverse transcriptase and RNA template, can synthesize telomere sequences de 
novo at chromosome ends1. Telomerase specifically lengthens the 3’ strand, and the 
lagging strand replication machinery can then fill in the opposite strand. This synthesis 
compensates the loss of sequence due to the “end replication problem.” We now 
recognize that the “end replication problem” is not directly due to the primer removal 
event on the lagging strand, but rather the processing of the leading strand to generate a 
3’overhang substrate for telomerase (Figure 1; ref. 10). In species that do not contain 
telomerase, other mechanisms have evolved to solve the problem. For example, in 
Drosophila, retrotransposons insert near chromosome ends, thus maintaining 
chromosomal integrity11.  
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Figure 1. Telomerase helps solve the “end replication problem.” 
At the end of a linear chromosome, DNA polymerase can synthesize the leading strand 
until the end of the chromosome. On the lagging strand, however, DNA polymerase's 
synthesis involves synthesis of series of fragments, called Okazaki fragments, each 
requiring an RNA primer. Without DNA to serve as template for a new primer, the 
replication machinery is unable to synthesize the sequence complementary to the final 
RNA primer. Meanwhile, the leading strand synthesis generates a blunt end, which is 
processed by nucleolytic activity to generate a 3’ overhang. The result is the "end-
replication problem" in which sequence is lost during each round of DNA replication. 
Telomerase acts on the 3’overhang at chromosomal termini and synthesizes telomeric 
repeats de novo to counteract the sequence loss.  
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In humans, telomerase is active only during embryogenesis, in immature germ 
cells and in a subset of stem/progenitor cells during postnatal life12. Telomere length can 
be maintained or increased by telomerase, a process that appears to be regulated by a 
variety of telomere-binding proteins that control telomerase recruitment and activity at 
the telomeres. During mammalian embryogenesis, telomerase is strongly activated at the 
morula/blastocyst transition by transcriptional activation of the catalytic subunit. At this 
transition, telomeres are significantly elongated in murine and bovine embryos. Early 
embryonic telomere elongation is telomerase-dependent and leads to a rejuvenation of 
telomeres in somatically cloned bovine embryos. Understanding the molecular 
mechanisms underlying this early embryonic telomere elongation program is of great 
interest for medical research in the fields of regeneration, cell therapies and therapeutic 
cloning.  
Many essential components and regulation mechanisms of telomerase are 
conserved between yeast and mammalian systems. Unlike mammalian cells, S. cerevisiae 
telomerase is active in all dividing cells. Genetic tools have been well developed and 
make it easier to study the function and regulation of telomerase than in mammalian 
systems.  
   
Telomeres and Telomere End Structure 
In addition to facilitating DNA replication by solving the end replication problem, 
telomeres have many other functions including protecting chromosome ends from being 
recognized as broken ends by the DNA repair machinery, protecting chromosomes from 
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degradation by nucleases, regulating gene expression and serving as a biological clock to 
control the replicative capacity of a cell1.  
First sequenced in Tetrahymena thermophila by Liz Blackburn9, telomeres are 
GC-rich repetitive sequences found at eukaryotic chromosomal ends.  A given species 
has a characteristic telomeric repeat sequence and also a characteristic length. Human 
telomeres contain ~10-15 kb CCCTAA/TTAGGG telomere sequence and mouse 
telomeres contain ~2-50kb of the same sequence13. Other vertebrates, trypanosomes, 
acellular slime molds, and filamentous fungi contain the same telomeric sequences.  In 
contrast, S. cerevisiae telomeres contain 250-350bp of (TG)0-6TGGGTGTG(G) sequences 
and S. pombe telomeres repeats can be loosely abbreviated as GGTTACAG0-414.  
Telomeres contain both double stranded telomere sequences and a single-stranded 
3’overhang (G-tail). These sequences contain binding sites for telomere-associated 
proteins that cap chromosome ends, regulate telomerase recruitment and telomere length. 
Human telomeres contain a G-tail of 75-300bp throughout the cell cycle13. The single-
stranded G-tail invades into the double-stranded region and forms a structure called the 
T-loop15. Formation and stabilization of the T-loop is facilitated by the shelterin/telosome 
complex, a network of many telomere-associated proteins (Figure 2; ref. 16). Shelterin 
contains proteins that bind to the G-tail such as the POT1/TPP1 heterodimer, and proteins 
that bind to the double-strand repeats. These include the Myb-domain-containing 
telomere binding factors TRF1 and TRF2 and their associated proteins RAP1, TIN2 and 
TPP1, proteins that generally have roles in telomere capping and length regulation.  
TRF1 specifically associates with duplex TTAGGG repeats, and diminished TRF1 
loading on telomeres leads to telomere over-extension, but not telomere capping 
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A.  
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Figure 2.  Human Telomeres and Shelterin16. 
            A. Schematic of human telomeres in the “open” and “t-loop” state.  
B. Schematic of the overall composition of Shelterin. See text for details.
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defects. Artificially tethering TRF1 to telomeres results in telomere shortening, 
suggesting a negative role of TRF1 in regulating telomere length4. TRF2 shares 
homology with TRF1, and overexpression of TRF2 results in the progressive shortening 
of telomeres, similar to the phenotype observed with TRF117. In vitro experiments 
demonstrated that Trf2p promotes the formation and possibly maintenance of the “t 
loop”18. Trf2p was observed bound to the t loop-tail junction, where the terminal G-tail 
overhang strand invades the duplex DNA, producing a displacement loop of up to 300 
nucleotides. hRap1p interacts with TRF2. Although hRap1p has a role in telomere length 
regulation and affects telomere length heterogeneity19, 20, it doesn’t bind to telomeric 
DNA directly19. 
 Telomerase function is also regulated by the Protection of Telomeres (POT1) 
protein. POT1 and TPP1 form a heterodimer, and TPP1 is required to recruit POT1 to 
telomeres. POT1 interacts with telomeres both through directly interacting with the 3’ 
single stranded G tail and through interaction with TPP11. The POT1-TPP1 telomere 
complex also serves as a telomerase processivity factor during telomere extension in 
vitro21, though the significance of this observation in vivo is not understood.  
Although some components are shared, the telomeres of S. cerevisiae have a 
different set of telomeric proteins and structure than their human counterparts. The length 
of the G-tail is cell-cycle regulated. The G-tail is normally 12-15 nucleotides long, but in 
late S phase when telomeres are replicated, it increases to 50-100 nucleotides 22, 23. There 
is thought to be no large T-loop formation in S. cerevisiae as in humans. However, 
protein-protein interactions between telomere associated proteins Sir2p, Sir3p and Sir4p 
and histones H3 and H4 form a heterochromatin structure at telomeres that results in 
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transcriptional silencing of genes located close to telomeres (termed Telomere Position 
Effect)24. Proteins that associate with telomeres or subtelomeric regions include Cdc13p, 
Rap1p/Rif1p/Rif2p, Tel1p, and the Mre11p/Rad50p/Xrs2p complex. These proteins all 
have roles in telomere length regulation that will be discussed in detail below. 
 
Structure and Function of the Telomerase Complex 
First identified in ciliated protozoa, telomerase is highly conserved in eukaryotic 
evolution. As an obligate ribonucleoprotein (RNP), its catalytic function requires two 
components: the TERT protein (Telomerase Reverse Transcriptase) and the RNA 
(alternately known as TR, TER or TERC or TLC1 in S. cerevisiae) 25-27. The telomerase 
RNA component contains a short stretch of residues complementary to the telomere 
repeat and serves as the template for reverse transcription by TERT28.  
TERT Structure and Function. The gene encoding the TERT protein was 
initially cloned from S. cerevisiae as EST2 and subsequently from ciliated protozoa 
(Euplotes aediculatus). Generally, TERTs can be divided into three conserved functional 
domains, an N terminal region (Figure 3; TEN domain in S. cerevisiae; RID1/I-A+N-
DAT+I-B in hTERT), an RNA interacting region (RBD in S. cerevisiae and RID2 in 
hTERT) and a C terminal RT domain. The Reverse Transcriptase domain is the most 
highly conserved part of protein and is shared with viral reverse transcriptases and 
telomerases from different species29. Three absolutely conserved aspartate residues are 
required for catalytic activity. In addition to reverse transcriptase activity, TERT also has 
other functions such as interacting with other components of the telomerase complex and 
with the DNA substrate. Most species also have a C terminal extension region (CTE) that 
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has been implicated in promoting telomerase processivity and localization but not in 
catalytic activity per se.  
Interactions between telomerase and its DNA substrate (the chromosome 3’ 
terminus) are critical to the correct activity and regulation of the enzyme. Specific 
primer-substrate interactions of telomerase are mediated by hybridization of the DNA 
substrate to the RNA template and also by interaction of the chromosome terminus with a 
single-stranded DNA binding site (called the “anchor site”) in the telomerase complex. 
The presence of an “anchor site” has been suggested in many species including 
Tetrahymena, Euplotes, yeast and human30-33. 
In human TERT, anchor-site interactions have been mapped to the N-terminal 
RID1 domain and the C terminal CTE domain (Figure 3). Several NAAIRS substitutions 
(a six-amino acid sequence that less likely disrupts protein structure) within the N-
DAT domain have been reported to Dissociate the biological and catalytic Activities of 
Telomerase. These mutants have nearly normal catalytic activities, but do not support 
telomere replication in vivo. This activity is partially or fully rescued by fusing the 
mutant hTERT to POT1, a protein bound at the chromosome terminus. This result 
suggests that some DAT sequences may be important for the recruitment and/or 
activation of telomerase32. More recently, it has been suggested that many of these 
mutants may not truly maintain normal catalytic activity. Some DAT mutants impair 
telomerase processivity on short telomeric primers in a conventional telomerase assay. 
Given that this assay is thought to be sensitive to the strength of telomerase-primer 
interaction, it is possible that DAT sequences are important for the specificity and affinity 
of telomerase-DNA interactions34. Thus these residues would meet the definition of an 
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anchor site. In a direct primer binding assay, hTERT forms stable and specific contacts 
with telomeric DNA in the absence of the human telomerase RNA component (hTR)35. 
The first 350 amino acids of hTERT have a critical role in regulating the strength and 
specificity of these protein-DNA interactions, providing additional evidence that the 
TERT N terminus contains an anchor site. The same appears true of yeast TERT. S. 
cerevisiae telomerase remains tightly bound to its reaction products in a manner 
dependent on the 5’ end of telomeric primers36. Mutational analysis and crosslinking 
experiments have mapped the anchor-site to the N-terminal Region I of Est2p in S. 
cerevisiae33. Further structure modeling and mutational analysis reveal a positive patch 
on the surface of Region I structure (including residues R151 and N153) that appears to 
modulate the interaction between Est2p and its primer/substrate37.   
The oligomeric state of the telomerase complex is still unresolved. Both TERT 
and TR have been shown capable of forming dimers. Evidence for physical and 
functional dimer formation have been reported for human, yeast and Euplotes crassus. 
Two separate, catalytically inactive hTERT proteins can complement each other in trans 
to reconstitute catalytic activity, suggesting that hTERT multimerizes in vivo38. This 
complementation requires the amino terminus of one hTERT and the reverse 
transcriptase and C-terminal domains of the second hTERT. The telomerase RNA must 
associate with only the latter hTERT for reconstitution of telomerase activity to occur. 
RID1 and RID2 in hTERT physically interact with RT-CTE in absence of RNA in vitro, 
suggesting that these regions are important for telomerase dimerization39. Est2p has been 
shown to dimerize in vivo in a manner dependent on T motif and RT domain 40. However, 
the functional relevance of dimerization is still not understood. 
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Telomerase RNA. In contrast to TERTs, the RNA subunits are highly divergent 
among different species, varying in both size and sequence composition from ~150 nt in 
ciliates and ~450 nt in vertebrates to ~930-1300 nt in the budding yeasts Kluyveromyces 
lactis and Saccharomyces cerevisiae41. Secondary structures of ciliate and vertebrate 
RNAs have been proposed by phylogenetic analysis and determined by mutational 
analysis (Figure 3B). All TERs contain a 5’ template boundary element (TBE; a structure 
that limits reverse transcription), a large loop that includes the template, a potential 
pseudoknot and a loop-closing helical region41. However, the vertebrate and yeast RNAs 
have acquired additional structures that serve to bind species-specific proteins. TLC1 
RNA in S. cerevisiae serves as a flexible scaffold that interacts with other components of 
telomerase42. Its pseudoknot binds Est2p, while a stem loop structure binds to Est1p. Sm 
proteins stablize TLC1 RNA and Ku also binds to a 48 nt stem loop structure that is 
important for telomerase recruitment in G1 and S phase. Deleting much of the RNA that 
separates these protein-binding elements generates a 500 nt mini-RNA molecule that is 
functional in vivo, although the telomeres are stably shorter than wild-type strains43. This 
results in decrease in hTR levels, and is accompanied by telomere shortening. Indeed, 
mutations in hTR have also been found to cause autosomal dominant DC44. These 
mutations are found mostly in the pseudoknot and CR4/VR5 domains that are required 
for telomerase catalytic activity. Mutations in TERT have been identified in DC patients 
too, further supporting that DC patients with dyskerin, hTR and TERT mutations suffer 
from defective telomerase function44. 
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Figure 3. Structures of TERT and TR. 
A. Functional Domains in hTERT and ScEst2p. See text for description. 
B. Secondary structures of ciliate, vertebrate, and S. cerevisiae telomerase RNAs 41.  
 Structural elements in green represent conserved regions that bind to TERT. The  
 structures that are present in some but not all species within a group are shown by  
 dashed lines. The structures that define template region (red) and the template  
 boundary (blue) are indicated. The RNA structural elements bound by protein  
 components are indicated. In the Saccharomyces RNA, a proposed stem-1 that would  
 form a pesudoknot is indicated by red brackets. 
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 Other Components of Yeast Telomerase 
Besides TERT (Est2p) and TR (TLC1 RNA), yeast telomerase also has other 
components, Est1p and Est3p, that were identified in a screen for genes that when 
deleted, cause progressive telomere shortening and senescence  (referred to as EST [ever 
shorter telomere] phenotype)45.  These accessory proteins are dispensable for in vitro 
telomere addition but are required for telomerase activity in vivo27.  
Est1p binds to TLC1 RNA via a bulged stem structure (Figure 3B; ref. 46). It has 
weak single-strand G-rich DNA binding activity, though the relevance of this activity in 
vivo is unclear. Est1p interacts with Cdc13p, a single-stranded DNA binding protein 
involved in telomere capping and telomerase length regulation47.  These two proteins 
directly interact and collaborate to positively regulate access of telomerase to the 
telomeres. Fusion of Est1p to the DNA binding domain of Cdc13p over-elongates 
telomere length, suggesting that their interaction is normally regulated48. Est1p also 
regulates telomerase assembly during the cell cycle. Its level is low in G1 phase because 
of proteasome-dependent degradation and this low protein level restricts telomerase 
assembly in G1 phase49.  
Like Est1p, Est3p interacts with the telomerase complex, although its role is 
largely unknown. Interaction of Est3p with TLC1 is dependent on Est2p, and its assembly 
into the telomerase complex in G1 is dependent on Est1p49. Overexpression of Est3p 
rescues the growth of temperature-sensitive mutations in Region I of Est2p, suggesting 
that Est3p might interact with Est2p through this N-terminal region50.  Wide-scale 
mutagenesis analysis and sequence alignment within fungal species shows that Est3p has 
three functional domains: N-terminal Region, Central region and C-terminal region 
 14 
(Margaret Platts, unpublished data). Est3p dimerizes in vitro, and mutations that disrupt 
dimerization causes telomere shortening51. Est3p also weakly unwinds RNA-DNA 
duplex in vitro52. However, the in vivo relevance of these activities is unclear.  
PinX1 is an essential protein involved in rRNA and snoRNA maturation, and 
overexpression of PinX1p results in telomere shortening and reduced telomerase activity 
in vitro40. PinX1 coimmunoprecipitates with the same region of Est2p that interacts with 
TLC1 RNA. As such, Est2p and PinX1 appear to form mutually exclusive complexes 
with TLC1 RNA such that the level of one is up-regulated when the other is down-
regulated. This observation suggests that PinX1 regulates telomerase activity by 
sequestering Est2p from complexing with TLC1 RNA. Human PinX1 also forms a 
complex with hTR to inhibit telomerase activity, suggesting a conserved role of PinX1 in 
regulating telomerase53. 
TLC1 RNA also contains a canonical binding site for Sm proteins, which are 
essential for the assembly of small nuclear RNPs involved in mRNA splicing54. Sm 
proteins bind to the TLC1 RNA and are retained in the active complex following 
assembly. Mutations in the Sm binding site of TLC1 severely reduce RNA levels and 
cause telomere shortening. The Sm proteins may be required for removal of the poly(A) 
tail from TLC1 precursor and hypermethylation of the 5’ 7-methylguanosine cap of 
TLC1. 
 
Other Components of Human Telomerase  
Iterative profile searches have identified three human homologs of the yeast 
telomerase subunit Est1p, hEST1A, hEST1B and hEST1C55. These proteins all contain 
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weak sequence similarity with yeast Est1p. Both hEST1A and hEST1B proteins 
specifically associate with telomerase activity in human cell extracts and bind hTERT in 
rabbit reticulocyte lysates independently of the telomerase RNA56. Overproduction of 
hEST1A cooperates with hTERT to lengthen telomeres, an effect that is specific to cells 
with detectable telomerase activity. Like Est1p, hEST1A (but not hEST1B) exhibits a 
single-stranded telomere DNA binding activity. These results suggest that the telomerase-
associated factor Est1p is evolutionarily conserved in humans.  
The molecular chaperones p23 and Hsp90 associate with hTERT, promoting the 
in vitro assembly of hTR and hTERT in rabbit reticulocyte lysate57. The S. cerevisiae p23 
homolog Sba1p has a role in telomerase-mediated telomere extension by modulating the 
DNA binding activity of telomerase58, suggesting that a requirement for chaperone 
functions is a conserved aspect of the telomerase complex. 
                        
                                     Telomere Maintenance Mechanisms 
In most species, telomeric DNA is maintained at a particular length by a dynamic 
process that includes a variety of proteins including telomerase. In S. cerevisiae, most 
strains have a length of TG1-3 repeats that varies between 225~375bp (reviewed in 59). In 
contrast to yeast, human cells show telomere attrition with cell division, which results 
from limiting amount of telomerase activity in the adult organism that cannot compensate 
for progressive telomere shortening that occurs as cells divide.  Cancer cells frequently 
maintain very short telomeres, but only slightly longer than the length needed to prevent 
uncapping.  
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Maintenance by Telomerase 
In all organisms studied to date, the single-stranded G-tail is the substrate for 
telomerase activity. In absence of telomerase, telomeres shorten as cells divide. As a 
result, processes affecting the expression/stability of telomerase components, and the 
assembly or localization of telomerase can influence telomere length. For example, 
mutations that destabilize the RNA template can cause telomere shortening and 
senescence. 
In human cells, the telomerase RNA is ubiquitously expressed and the absence of 
telomerase activity in somatic cells is due to the lack of expression of the TERT subunit. 
Introduction of ectopic hTERT is sufficient to allow in vitro telomerase activity and life-
span extension of some cell types60, 61. Also, expression of hTERT correlates very well 
with telomerase activity (for example, in tumor cells), while expression of hTR does not.  
Concomitant overexpression of hTERT and hTR is necessary and sufficient to increase 
telomerase activity and telomere length becomes substantially longer than physiological 
size in less than 50 passages62. These results imply that telomerase is normally limiting 
for elongation of telomeres in human cells. 
Consistent with this idea, cells that have half the level of the telomerase RNA 
cannot maintain telomere length through multiple cell divisions. As mentioned earlier, 
people who are heterozygous for mutations in the telomerase RNA have the diseases 
dyskeratosis congenita and/or aplastic anemia. Symptoms are manifested in highly 
proliferative tissues and are thought to result from short telomeres that impair tissue 
renewal capacity. Mice heterozygous for telomerase RNA show haploinsufficiency in 
telomere length maintenance and also show loss of tissue renewal capacity. Furthermore, 
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genotypically wild-type mice derived from heterozygous parents with short telomeres 
display hematopoetic stem cell defects and short telomeres (so called “occult” disease), 
suggesting that telomere length determines these phenotypes and that normal telomerase 
level is limiting and can’t rescue the short telomere phenotype63. In S. cerevisiae, a 
TLC1/tlc1Δ heterozygote maintains shorter telomeres and this haploinsufficiency is 
consequence of the low TLC1 RNA level64. The number of TLC1 RNA molecules in a 
haploid yeast cell has been estimated to be ~29, less than the number of chromosome 
ends (64) in late S-phase. Wild-type diploid cells contain approximately 37 telomerase 
RNAs, while diploids heterozygous for a null tlc1 allele have half the wild-type amount, 
approximately 19 TLC1 molecules. Based on these observations, telomerase is 
outnumbered by its substrates in late S phase. In support of this idea, sequencing and 
analysis of telomere addition events from one cell cycle show that not all telomeres are 
extended by telomerase in one cell cycle, and that the shorter telomeres are preferentially 
elongated. The ability of telomerase to preferentially target the shortest telomere is a 
conserved property of the enzyme and is likely critical for genomic stability in the face of 
limiting telomerase levels. 
 
Alternative Lengthening of Telomeres 
In the absence of telomerase activity, both mammals and yeast are able to 
maintain or even amplify their telomeric and/or subtelomeric DNA through 
recombination-dependent mechanisms. This phenomenon was first described in budding 
yeast strains lacking the EST1 gene65. Telomeres in S. cerevisiae are normally a few 
hundred base pairs in length and shorten at 3-5 bp per cell division in the absence of 
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telomerase. Telomeres of telomerase-deficient mutants shorten to less than ~100bp 
before most cells stop dividing and enter replicative senescence28, 45, 66. Rarely, survivors 
arise from Rad52p-dependent recombination pathways. There are two types of survivors, 
Type I and Type II.  Initially described by Lundblad and Blackburn65, Type I survivors 
amplify the subtelomeric Y’ sequences that exist at more than half of yeast chromosome 
ends. Telomeres of Type II survivors are more heterogeneous in length, with few 
alterations in subtelomeric sequences. Recent evidence suggests that a roll-and-spread 
mechanism is responsible for Type II survivor formation67. A small circle of telomeric 
DNA, possibly resulting from an intratelomeric deletion, is used as the template for 
rolling-circle replication, resulting in an elongated telomere. Sequence of this first 
elongated telomere can subsequently be spread to all other telomeres through 
recombination events. Type II survivors arise less frequently than Type I survivors. 
However, they grow faster and eventually overgrow Type I survivors in liquid cultures. 
In absence of Rad52, neither Type I nor Type II survivors can form. The appearance of 
Type I survivors depends on the “canonical” homologous recombination proteins Rad51, 
Rad54, Rad55 and Rad5768, 69.The Type II pathway requires the MRX (Mre11-Rad50-
Xrs2) complex and Rad5968-71.  
 
Telomere Maintenance and Cancer  
Reactivation of a telomere maintenance pathway to prevent telomere loss is a 
critical step in cancer development. Most cancer cells (~90%) maintain telomeres by 
reactivating telomerase. However some cancer derived mammalian cell lines maintain 
telomere length by a telomerase-independent mechanism termed ALT (Alternative 
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Lengthening of Telomeres)72. ALT cells have an extremely heterogeneous telomere 
length. For comparison, telomeres of human somatic cells shorten 40-200bp/cell division 
until cells senesce at a length of ~5-8kb8, 73-75. Human germ line cells maintain their 
telomere length at ~15kb by telomerase, while human cancer cells and immortal cells 
with active telomerase have a telomere length of less than 10kb76-78. In contrast, ALT cell 
lines have a very broad telomere length distribution ranging from <3kb to >50kb, with an 
average of ~20kb72, 79-82. ALT cells have specific nuclear structures, referred to as ALT-
associated PML Bodies (APBs), that contain telomeric DNA, TRF1 and TRF2, and also 
proteins involved in telomere binding, DNA replication, repair and recombination 
processes83. These structures might facilitate the ALT mechanism or sequester 
extrachromosomal telomeric DNA generated by ALT. Telomere lengthening in ALT 
cells is dependent on recombination, but the exact substrates are unclear. These events 
could be inter-telomeric or intra-telomeric recombination in the context of a T-loop, 
extrachromosomal recombination with a circular molecule, or recombination between 
linear chromosomes. These changes are highly reminiscent of Type II survivors in yeast.  
 
Telomere Length Regulation 
Telomere length is maintained through a balance of activities that shorten 
telomeres (by negative regulators) and activities that lengthen telomeres (such as 
telomerase). Proteins that influence the activity or access of telomerase at the telomere 
terminus are therefore important players in telomere length regulation. There are two 
major classes of such proteins: proteins that are involved in telomeric chromatin 
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formation/modification, and proteins that influence lagging-strand replication and may 
help coordinate telomerase synthesis with C-strand replication. 
 
Negative Regulators of Telomere Activity/Access 
Rap1p. Rap1p negatively regulates telomere length through its cofactors Rif1-
Rif2 (Rap1-interacting factor 1 and 2) 2, 84, 85. Artificially targeting Rap1p or Rif1p/Rif2p 
to an individual telomere proportionally shortens telomere length. Rif1p and Rif2p 
restrict the accessibility of telomeres to telomerase based on the observation that in rif1Δ 
and rif2Δ strains the frequency of telomere addition is increased while the preferential 
lengthening of short telomeres persists86.  
Pif1p. Pif1p is a helicase that belongs to the SFI helicase superfamily and is 
conserved from yeast to humans. Yeast Pif1p is involved in the maintenance of 
mitochondrial, ribosomal and telomeric DNA and may also have a general role in 
chromosomal replication by affecting Okazaki fragment maturation87. Pif1p prefers an 
RNA-DNA hybrid substrate in vitro88. In vivo, overexpression of Pif1p reduces 
telomerase association with telomeres, whereas depleting cells of Pif1p increases the 
levels of telomere-bound Est1p, suggesting that Pif1p limits telomerase function by 
removing telomerase from telomeres89. Negative regulation of telomerase may be 
mediated via the interaction of Pif1p with the finger subdomain of the RT domain in 
Est2p90.  
Lagging Strand Replication Machinery. Many proteins that are involved in 
lagging-strand replication also negatively influence telomere length. During DNA 
replication, it is widely accepted that removal of the RNA primer on the end of the 
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lagging strand or processing of the leading strand leaves a 3’ overhang that serves as the 
substrate for telomerase. Replication of the complementary C-rich strand is accomplished 
by the conventional lagging-strand replication machinery. Mounting evidence suggests 
that telomere synthesis by telomerase is tightly co-regulated with the synthesis of the 
opposite C-strand.  Such coordination may prevent telomerase from generating 
excessively long single-stranded tails, which may be deleterious to chromosome stability 
in S. cerevisiae.  
Several lines of evidence link DNA replication to telomere length regulation. In 
S. cerevisiae, Polα, Polδ and DNA primase are required for telomerase-mediated 
telomere addition in vivo91. Co-immunoprecipitation (CoIP) experiments in S. pombe 
showed that Polα interacts with TERT, indicating that these proteins may form a complex 
in vivo92. Aphidicolin, an inhibitor of Polα and Polδ, causes abnormal lengthening of the 
G-strand and concomitant increased C-strand heterogeneity of telomeres in the ciliate 
Euplotes93, and Euplotes telomerase physically associates with primase, a component of 
the lagging-strand machinery94. In agreement with the role for lagging-strand replication 
in telomere homeostasis, mutations in many components of the lagging-strand replication 
machinery (such as Polα, RFC, Elg1p, Dna2p and Rad27p) cause telomere over-
elongation95-98.  
How lagging strand replication and telomere elongation are coordinated is 
currently unclear. Cdc13p, a single-stranded telomeric DNA binding protein, may play a 
role in this coordination. Cdc13p is involved both in telomere capping through interaction 
with Stn1p 99 and in telomerase recruitment to the telomeres 48. Cdc13p is proposed to 
regulate telomere length in two steps-first positive and then negative. In its positive role, 
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Cdc13p activates telomerase through its interaction with Est1p 48, 100.  Remarkably, direct 
fusion of the DNA-binding domain of Cdc13p to the catalytic subunit of telomerase, 
Est2p, eliminates the requirement for Est1p in telomere maintenance 48. However, 
telomeres in this strain are significantly over-elongated, suggesting that these interactions 
must be regulated. Cdc13p then binds Stn1p, which prevents telomerase recruitment to 
telomeres, subsequently limiting G-strand synthesis by telomerase in response to C-
strand replication 101. Cdc13p physically interacts with the catalytic subunit of DNA 
polymeraseα, a component of the lagging-strand machinery, suggesting a link between 
telomere addition and DNA lagging- strand replication 47. Intriguingly, mutations that 
weaken the Cdc13-Pol1p interaction result in telomere over-elongation.  However 
because apparent complete loss of this interaction only slightly increases telomere length, 
additional mechanisms may contribute to the coordination of telomerase activity with 
lagging-strand replication.   
 
Positive Regulators of Telomerase Activity/Access 
Tel1p and Tel2p. Tel1p and Tel2p are positive regulators of telomere length 102, 
with loss of these proteins leading to short but stable telomere length. In a tel1Δ strain, 
the addition of synthetic Rap1p-binding sites at a telomere fails to cause telomere 
shortening as observed in wild-type or yku70Δ strains 103. Importantly, rap1 tel1 double 
mutants exhibit the shorter than normal telomeres characteristic of tel1 mutants 104. These 
results have led to the proposal that Rap1p negatively regulates the telomerase-
recruitment activity of Tel1p so that loss of Rap1p function is inconsequential in the 
absence of Tel1p104. Recent research suggests that Tel1p preferentially binds to shorter 
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telomeres and stimulates their elongation via telomerase, consistent with the role of Tel1p 
downstream of the Rap1p/Rif1p/Rif2p complex86.  
Ku70/80 heterodimer. A heterodimer of the yKu70 and yKu80 proteins interacts 
with a 48nt stem-loop in TLC1 RNA and is essential for recruitment of telomerase to 
telomeres in G1. In S phase, recruitment of telomerase to telomeres through Cdc13p-
Est1p interaction plays a major role. Ku also protects against resection of the C-strand, 
thereby contributing to protection of chromosome termini105. Deletion of YKU70 or 
YKU80 results in short but stable telomeres with a long single-stranded G-tail throughout 
cell cycle106, 107. A tel1 yku70 double mutant has a telomere length shorter than either 
single mutant, suggesting that TEL1 and YKU70 are in separate telomere regulatory 
pathways106. 
Mec1p. Mec1p is the homolog of the human ATR checkpoint protein and 
negatively regulates telomere length. Deletion of Mec1p results in modest telomere 
shortening. The functions of Mec1p and Tel1p are redundant in recruitment of telomerase 
and tel1Δ mec1Δ strain has an est phenotype71. They are present at telomeres at different 
times in the cell cycle in a mutually exclusive manner108. In particular, Mec1p is 
associated with telomeres in late S phase.  However, since the telomere shortening 
experienced in a mec1Δ strain is very slight, Tel1p appears largely redundant for Mec1p 
function at telomeres. 
MRX complex. Mre11p is a subunit of the MRX (Mre11-Rad52-Xrs2p) 
complex, which is required for efficient homologous and non-homologous repair of 
double-stranded DNA breaks and for activation of the S phase checkpoint109, 110. Deletion 
of any one protein or all three results in short but stable telomeres, and this phenotype is 
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not exacerbated by tel1Δ, suggesting that the MRX complex and Tel1p function in the 
same pathway102. The defect of tel1Δ mec1Δ can be bypassed by eliminating the Rif 
proteins111. Taken together, these data suggest that Tel1p, the MRX complex and Mec1p 
function in a partially redundant manner to promote the access of telomerase to 
telomeres. In tel1Δ and mre11Δ strains, the association of Est2p and Est1p with telomeres 
are severely reduced while mec1Δ has a nearly wild-type level, suggesting that Mre11p 
and Tel1p affect telomere length by promoting telomerase recruitment to telomeres, 
whereas Mec1p has only a minor role in telomerase recruitment when Tel1p is present112. 
In a genome-wide screen for telomere length regulators in S. cerevisiae113, 
proteins with very diverse functions were identified. Besides proteins mentioned above, 
proteins were identified that function in vacuolar trafficking (for example, components of 
the Endosomal Trafficking complex), in DNA and RNA metabolism (for example, RNA 
polymerase II subunits), and in DNA modifications (for example, Rpd3 histone 
deacetylase complex, Mediator, and Nup60). For most of these genes, their roles in 
telomere length regulation (either direct or indirect) are not understood.  
 
Telomere Position Effect 
Proteins that comprise the telomeric heterochromatin also influence telomere 
length. Chromatin at telomeres has several characteristics that are similar to those of 
heterochromatin at pericentromeric regions, such as ability to silence nearby genes, 
which is termed “telomeric silencing” or “Telomere Position Effect” (TPE). Both 
mammalian and yeast cells demonstrate TPE.  
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In budding yeast, Rap1p and the Sir proteins are involved in establishing TPE114, 
115. At telomeres, Sir proteins are recruited through their interactions with C-terminal 
residues of the telomere binding protein Rap1p, which also binds to Rif1p and Rif2p. 
This initial interaction promotes additional Sir binding which can spread to subtelomeric 
regions and interact with the N-terminal tails of histones H3 and H4, promoting their 
hypoacetylation and leading to transcriptional repression.  Rap1p binds directly to 
double-stranded telomeric DNA and interacts directly with Sir4p116. Sir4p in turn recruits 
Sir2p and Sir3p. The NAD-dependent histone deacetylase Sir2p can deacetylate histone 
H4 followed by the binding of Sir3p and Sir4p to histone tails at subtelomeric regions, 
promoting the formation of heterochromatin and spreading of telomeric silencing117. 
These protein-protein interactions are thought to “fold back” the telomeres and form a 
higher-order structure that further promotes and stabilizes protein-protein interactions. 
Mutations in Sir proteins disrupt telomeric silencing and cause telomere shortening, 
though the mechanism through which Sir proteins normally positively regulate telomere 
length is not understood118.  
The relationship between telomere length and gene silencing is complex. A gene 
adjacent to a long telomere shows higher and more stable repression than a gene next to a 
shorter telomere119. However, there is no absolute positive link between TPE and 
telomere length. For example, rif1Δ rif2Δ has abnormally long telomeres and increased 
TPE, and the increased TPE result from more Rap1 binding sites within the long 
telomeres and reduced competition for Sir binding85. In contrast, rap1ts has similar 
elongated telomeres but no TPE because of the elimination of Sir proteins binding by 
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rap1ts119. Likewise, tel1Δ has shorter telomere and normal TPE, while ku70Δ has shorter 
telomere and reduced TPE120, 121. 
 
Importance of Telomere Length Regulation (Cancer and Aging) 
The role of telomerase in cancer has been implicated for three decades. Over 90% 
of tumor cells show up-regulated telomerase activity. A large body of research on the 
dynamics of telomerase activity and telomere regulation has led to the following model 
of tumor progression. Since most somatic cells have little or no telomerase activity, 
telomeres shorten as a cell divides. These cells eventually enter senescence when 
telomeres are critically short (M1; Mortality Stage 1). However, a small portion of cells 
can bypass senescence if checkpoint proteins such as p53 and pRb are non-functional.  
Telomeres in such cells continue to shorten until the cells enter crisis, a predominantly 
lethal condition in which loss of telomere capping leads to chromosomal instability and 
accumulation of mutations (M2). At this point, if cells reactivate telomerase or the ALT 
pathway to maintain critically short telomeres, chromosomes are stabilized and immortal 
growth can be achieved. Progression to a tumorigenic state requires additional mutations 
in genes that regulate cell proliferation, the occurrence of which might be increased 
during the severe genomic instability encountered during crisis. In this model, although 
short telomeres serves as a tumor suppressing function initially (M1), after the bypass of 
this checkpoint, short telomeres drive chromosomal instability and increase the 
possibility of tumor formation.  In support of this model, ectopic expression of hTERT is 
sufficient to maintain telomere length and immortalize telomerase negative human 
cells122, 123. Ectopic expression of TERT, SV40 Large T-antigen (to inactivate p53 and 
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pRb) and oncogenic Ras are sufficient to convert human epithelial and fibroblast cells to 
a tumorigenic state124. Most telomerase-positive cancer cells have short telomeres 
compared with their adjacent cells76, supporting the idea that cells experience severe 
telomere shortening as part of the tumorigenic process.  
Because of the role of telomerase in cancer, it has been a hot target for anti-cancer 
development. Oncolytic viruses that have the hTERT promoter driving critical adenoviral 
genes can selectively kill telomerase-positive cells. Direct enzyme inhibitors (including 
dominant-negative alleles, antisense oligonucleotides directed against the RNA subunit 
and RNAi) and cancer immunotherapy (hTERT peptide as antigen) are being explored 
with different levels of success.  It is hypothesized that there are cancer stem cell that 
have self-renewal capacity and are telomerase positive, so that anti-telomerase drugs 
might be more specifically targeted to these cells than are normal anti-cancer agents. 
As described earlier, the link between telomere dynamics and aging can be 
observed in a human disease Dyskeratosis Congenita (DC), which is a disorder that 
associates with abnormal pigmentation, nail dystrophy and bone failure. Mutations in 
hTR itself or genes governing hTR stability have been identified in DC patients. The 
onset of this disease occurs at progressively younger ages in subsequent generations (a 
phenomenon termed anticipation), most likely because of the inheritance of progressively 
shorter telomeres. mTerc-/mTerc- mouse models also show premature aging.  Although 
to date a definitive connection between telomere dynamics and normal ageing in humans 
has not yet been established, accumulating evidence strengthens the idea that accelerated 
telomere attrition contributes directly to inherited degenerative conditions and several 
premature aging syndromes.   
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Significance of This Study 
Considering the roles of telomerase in cancer and age-related diseases, many 
aspects of telomerase activity and regulation will present potential targets of therapy. 
Yeast is an attractive model for the study of telomerase because many aspects of 
telomerase assembly and at least some aspects of regulation appear well conserved. Many 
pathways have been identified in this model system that regulate telomere length. Most 
previous studies have focused on the role of ScTERT (Est2p) in the positive regulation of 
telomere length. Here, I present data supporting a novel role of the N-terminal region of 
Est2p in the negative regulation of telomere length through an effect on Rap1p 
association with telomeres. I also describe a unique alteration in telomere sequences that 
occurs in several strains in which telomeres are overelongated, perhaps suggesting an 
altered mode of telomerase synthesis under these conditions.  
Chapter II describes the identification of several mutations (est2-LT) that cause 
telomere overelongation (the LT, or long telomere phenotype). I also identify the genetic 
pathway through which these mutations interact. In Chapter III, I describe an effect on 
Rap1p binding to telomeres in est2-LT strains and the dependence of the LT phenotype 
on the Rap1p counting mechanism. These mutations also alter telomere sequences. 
Possible mechanisms for these sequence changes have been explored. Chapter IV 
describes the materials and methods used to obtain these results. Chapter V summarizes 
these studies and proposes future directions to investigate the mechanisms underlying the 
LT phenotype of est2-LT. In the Appendix, I describe the investigation of possible 
interactions between Est2p and lagging strand replication components that regulate 
telomere length.  
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CHAPTER II 
 
IDENTIFICATION AND PHENOTYPIC CHARACTERIZATION OF est2-LT 
 
Work described in this chapter is included in the following manuscript: 
Hong Ji, Margaret H. Platts, Latif Dharamasi, and Katherine L. Friedman.  
Regulation of Telomere Length by an N-terminal Region of the Yeast Telomerase 
Reverse Transcriptase. Mol Cell Biol. 2005 Oct;25(20):9103-9114. 
 
Abstract 
Telomerase is a reverse transcriptase that maintains chromosome integrity 
through synthesis of repetitive telomeric sequences on the ends of eukaryotic 
chromosomes.  In the yeast Saccharomyces cerevisiae, telomere length homeostasis is 
achieved through negative regulation of telomerase access to the chromosome terminus 
by telomere-bound Rap1 protein and its binding partners, Rif1p and Rif2p, and positive 
regulation by factors such as Ku70/80, Tel1p, and Cdc13p.  Here we report the 
identification of mutations within an N-terminal region (Region I) of the yeast telomerase 
catalytic subunit (Est2p) that cause telomere lengthening without altering measurable 
catalytic properties of the enzyme in vitro.  These telomerase mutations affect telomere 
length through a Ku-independent mechanism, and do not alter chromosome end structure.  
While Tel1p is required for expression of the telomere-lengthening phenotype, Rif1p and 
Rif2p are not, suggesting that telomere overextension is independent of Rap1p.  Taken 
together, these data suggest that specific amino acids within Region I of the catalytic 
subunit of yeast telomerase play a previously unanticipated role in the response to Tel1p 
regulation at the telomere. 
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Introduction 
Telomeres are nucleoprotein structures that cap the ends of linear eukaryotic 
chromosomes.  In most species, these termini are composed of tandem, short G-rich 
repeats and associated protein complexes [reviewed in 125].  Telomeres play an essential 
role in genome stability by preventing recognition of the normal chromosome terminus as 
a DNA double-strand break.  However, the inability of the conventional DNA 
polymerase machinery to fully replicate terminal sequences results in gradual erosion of 
telomeric repeats, leading to checkpoint activation and cellular senescence.  In cells that 
maintain proliferative potential, this end replication problem is counteracted by 
telomerase, a reverse transcriptase capable of synthesizing telomeric repeats onto 
chromosome ends using an intrinsic RNA template 126, 127.  In budding yeast, TLC1 and 
EST2 encode the template RNA and reverse transcriptase subunit, respectively, of the 
catalytic core of the telomerase holoenzyme 28, 45, 128.  As predicted, strains lacking these 
genes undergo progressive telomere shortening and senescence [referred to as the EST 
(Ever Shorter Telomere) phenotype].  Mutations of three additional genes [EST1, EST3, 
and EST4 (CDC13)] result in the same phenotype 45, 66, 129.  However, unlike strains 
lacking EST2 or TLC1, strains bearing these mutations retain telomerase catalytic 
activity, suggesting that these proteins are essential regulators of telomere replication in 
vivo 27, 129. 
Est2p belongs to a family of proteins (TERT; TElomerase Reverse Transcriptase) 
that contains a domain characteristic of reverse transcriptases (RTs) in its C-terminal half 
128.  Sequence alignment among numerous TERT proteins as well as functional analysis 
in ciliates, yeast and human TERT 32, 50, 130-134 have identified three additional essential 
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regions [I, II, and III 134; also called GQ, CP, and QFP 132 or RID1 and RID2 133] within 
the N-terminal half of the protein.  Mutations within Regions II and III of Est2p result in 
loss of coimmunoprecipitation with TLC1 RNA 40, 134, suggesting that these regions 
participate in RNA binding.  Similar sequences are required for association of ciliate and 
human TERT with their respective telomerase RNAs 133, 135-137. 
 TERT Region I contributes several functions to the telomerase holoenzyme, many 
of which are incompletely understood.  The RID1 domain of human telomerase 
(corresponding to S. cerevisiae Region I) interacts with the telomerase RNA and 
contributes to repeat addition processivity and multimerization 39.  Mutations within a 
subset of these N-terminal residues of both yeast and human TERT (hTERT) abrogate 
telomere replication in vivo, while the catalytic activity of the enzyme is retained 32, 134.  
These residues define an N-terminal region of hTERT that Dissociates Activities of 
Telomerase (N-DAT domain).  A subset of N-DAT mutations are rescued by direct 
protein fusion of hTERT to telomere-binding proteins, suggesting that these residues 
contribute to the recruitment of telomerase to the telomere in vivo 138, 139. 
 Additional residues in the N-DAT domain have been implicated in primer 
association because substitution of these residues (amino acids 92-97) influences primer 
preference of the holoenzyme in vitro 140.  The existence of such a primer binding or 
anchor site in the telomerase enzyme has been inferred from a number of observations 31, 
141, 142 including the propensity of yeast telomerase to remain tightly bound to its in vitro 
reaction products in a manner dependent on the 5’ end of telomeric primers 36.  Because 
these 5' nucleotides lie outside of sequences predicted to base pair with the telomerase 
RNA, this observation implies an interaction between the primer and protein 
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component(s) of the complex.  Indeed, a telomeric primer can be crosslinked to Est2p, 
supporting the hypothesis that the anchor site lies in Region I of Est2p 33.  Finally, 
overexpression of yeast EST3 specifically suppresses temperature-sensitive mutations in 
EST2 Region I, suggesting that N-terminal residues of the yeast catalytic subunit may 
also play a role in recruiting the Est3 protein to the complex 50. 
In most species, telomeric DNA is maintained at a constant average length by a 
dynamic process that involves a number of regulatory proteins in addition to telomerase. 
In S. cerevisiae, telomere length varies between 225 and 375 base pairs [bp; reviewed in 
59].  This average telomere length is maintained by a balance between the telomere-
lengthening activity of telomerase and negative regulation of telomerase by the double-
stranded telomeric DNA binding protein Rap1p and its associated factors 84, 85, 143-145.  
Rap1p binds to the double-stranded telomeric repeats in yeast where it is thought to 
nucleate binding of a number of additional proteins to the telomere.  As the number of 
bound Rap1 molecules increases, the accessibility or activity of telomerase at the 
telomere decreases, thereby allowing Rap1p to effectively “measure” telomere length 
[reviewed in 17].  Recent results suggest that telomeres switch between telomerase 
accessible and inaccessible states and that Rap1p and its binding partners Rif1p and 
Rif2p are critical determinants of those states 86.  Mutations in RIF1 and RIF2, or C-
terminal mutations in RAP1 that prevent association of Rif1p and Rif2p with the 
telomere, result in telomere overelongation 84, 85, 143.  Although the precise mechanism 
through which the binding of Rap1p affects telomerase activity is not understood, this 
negative regulation is dependent on activity of the Tel1p kinase.  Deletion of TEL1 
results in significant telomere shortening 146.  Furthermore, deletion of TEL1 in rif1Δ or 
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rif2Δ strains or in a strain lacking the C-terminus of Rap1p reduces telomere length to the 
same degree as te1lΔ alone 103, 147.  Therefore, TEL1 acts downstream of RAP1, RIF1, 
and RIF2. 
In this chapter, I describe the identification of several mutations clustered within 
Region I of Est2p that result in overelongated telomeres (est2-LT alleles).  Although the 
est2-LT alleles lie in a region of Est2p that corresponds to residues implicated in primer 
binding, there is no evidence of defects either in primer binding or catalysis by 
telomerase immunopurified from est2-LT strains. Genetic epistasis analysis suggests that 
these mutations lengthen telomeres by a Tel1p-dependent mechanism, but are 
independent of Rif1p and Rif2p. I propose that these mutations in Est2p Region I 
influence a previously unrecognized regulatory function of the catalytic subunit, the 
nature of which is addressed in Chapter III.  
 
Results 
 
Identification of mutations in S. cerevisiae EST2 that increase telomere length 
In the course of analyzing telomere length in a large number of strains containing 
mutations within the N-terminal half of Est2p, we fortuitously identified three mutations 
[glycine 75 to alanine (G75A) and asparagine 95 to alanine or aspartic acid (N95A, 
N95D); Figure 1A] that resulted in telomere overelongation (Figure 4B, compare lanes 2, 
3, lanes 5, 6, and lanes 11, 12 with lanes 1, 4, 7, 10).  Of the 800 bp telomeric fragment 
derived from PstI digestion in the subtelomeric Y’ element (Figure 4B, line), 
approximately 250-350 bp comprises telomeric repeat sequences.  In this strain 
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background, G75A increased the average length of the terminal PstI fragment by 
approximately 30 bp, while N95A and N95D caused a 50 bp increase (20%).  25 other 
mutations in conserved and non-conserved residues of the N-terminal half of EST2 
caused telomeres to be maintained at normal or shorter-than-normal length [data not 
shown;50]. 
Because of the clustering of the est2-LT alleles in the primary amino acid 
sequence of Est2p, we screened within a 60 amino acid region encompassing EST2 amino 
acids 59 to 119 for additional mutations resulting in this phenotype.  Briefly, a plasmid 
encoding Protein-A tagged EST2 (ProA-EST2) was cleaved with PflMI and AflII (Figure 
4A) and the resulting gapped vector DNA was cotransformed into an est2::HIS3 yeast 
strain with an overlapping PCR product generated under mutagenic conditions (see 
Chapter IV).  Transformants recovered on media lacking uracil were restreaked three 
times (eliminating any senescent colonies bearing non-functional EST2) and the resulting 
healthy strains were screened for increased telomere length by Southern blot.  Of ~700 
colonies screened, four caused increased telomere length upon plasmid isolation and 
reintroduction.  All four plasmids contained a mutation of glutamic acid 76 to lysine 
(E76K).  Although several of these plasmids contained mutations in addition to E76K, 
subcloning revealed that the long-telomere phenotype was exclusively due in each case to 
the E76K mutation (data not shown).  In this strain, the E76K mutation increased average 
telomere length by about 100 bp (40%; Figure 4B, lanes 8 and 9). A mutation within 
Motif E of the reverse transcriptase motif of EST2 (est2-motifE; Figure 4A) was 
previously reported to cause telomere lengthening, equivalent to that described here 148. 
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Figure 4.  Mutations in Region I of Est2p cause telomere lengthening.  
A. Map of functional regions of Est2p.  Top:  Map of Est2p primary sequence indicating 
the locations of the reverse transcriptase domain and three N-terminal regions that are 
essential for telomere maintenance in yeast.  The location of the est2-motifE mutation is 
indicated 148.  Bottom:  Detailed map of Region I of Est2p.  The locations of mutations 
that result in telomere lengthening are indicated (G75A, glycine 75 to alanine; E76K, 
glutamic acid 76 to lysine; N95A, asparagine 95 to alanine; N95D, asparagine 95 to 
aspartic acid).  Unique AflII and PflMI restriction sites were used in a gap-repair 
strategy to identify additional alleles of est2-LT with the long telomere phenotype (see 
text).  
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B. Telomere length is increased in strains expressing plasmid-borne est2-LT alleles.  All 
strains are derived from YKF120 (est2::HIS3) and carry plasmids expressing wild-type 
or mutant Protein A-tagged EST2.  Genomic DNA from strains expressing ProA-EST2 
(Lanes 1, 4, 7, 10 and 13), ProA-est2-LTG75A (lanes 2 and 3), ProA-est2-LTN95A (lanes 5 
and 6), ProA-est2-LTE76K (lanes 8 and 9), ProA-est2-LTN95D (lanes 11 and 12) or ProA-
est2-motifE (lanes 14 and 15) was digested with PstI, separated in a 1.2% agarose gel, 
blotted and probed with telomeric DNA. The black bar indicates a smear of fragments 
derived from the 2/3 of yeast chromosomes that contain a subtelomeric Y’ element.  
Upper bands derive from non-Y’ telomeres and tandemly repeated Y’ elements.  The 
sizes of maker bands (M) are indicated. 
C. Telomere lengthening caused by est2-LTE76K is stable and independent of Rad52p.  
Strains YKF120 (est2::HIS3 RAD52; lanes 2-4) and YKF114 (est2::HIS3 rad52::LEU2; 
lanes 5-7) were transformed with pKF410-est2-LTE76K, a low-copy number vector 
expressing the ProA-tagged est2-LTE76K allele.  Transformants were restreaked once on 
–ura media and a single colony was grown to saturation in 5 milliliters liquid media 
lacking uracil.  Liquid cultures were serially diluted 1000-fold and allowed to regrow to 
saturation a total of 10 times.  Genomic DNA was harvested from samples 
corresponding to approximately 55 (lanes 2 and 5), 85 (lanes 3 and 6), and 115 
generations (lanes 4 and 7) after transformation of the mutant allele, digested with PstI, 
separated by gel electrophoresis and probed with a telomeric probe.  Control lane 
contains DNA harvested from YKF120 (est2::HIS3 RAD52; lane 1) transformed with a 
plasmid expressing Protein-A tagged wild-type EST2 (pKF410) and grown for a 
minimum of 115 generations.  Only the telomeric smear corresponding to Y’ 
chromosomes is shown. 
D. The est2-LTE76K allele is semi-dominant to wild type.  DNA from diploid strains   
      EST2/EST2 (DKF206; lane 1), est2-LTE76K/est2-LTE76K (DKF207; lane 2), and   
      EST2/est2-LTE76K (DKF208; lanes 3 and 4) was digested with PstI and subjected to   
      Southern blot as described above.  The sizes of marker bands are indicated (M).  
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Indeed, when this mutation was incorporated into a plasmid-borne, Protein A-tagged 
allele of EST2 and transformed into our est2::HIS3 strain, the extent of telomere 
lengthening was similar to that caused by the est2-LTN95A and est2-LTG75A mutations 
(Figure 4B, lanes 14 and 15). 
Because the ProA-EST2 allele causes slightly decreased telomere length (~50 bp), 
we were concerned that the effect of telomere lengthening by the est2-LT alleles might 
result from stabilization specific to the Protein-A tagged protein.  To address this 
possibility, est2-LTE76K was introduced into the chromosome at the endogenous locus (in 
the absence of the Protein-A tag) and telomere length was assayed by Southern blot.  
Under these conditions, the increase in telomere length was comparable to that seen with 
the plasmid-borne, tagged allele (data not shown; see also Figure 10A, lanes 1 and 2), 
confirming that the mutation does not simply counteract the negative effect of the epitope 
tag. 
In the absence of functional telomerase, most cells die after ~75 generations. 
However survivors arise that maintain heterogeneous telomeres through Rad52p-
mediated recombination 65.  To assess the role of recombination in telomere lengthening, 
a plasmid bearing the est2-LTE76K allele was introduced into an est2Δ rad52Δ strain and 
the resulting transformants were grown for ~115 generations in liquid culture.  Telomere 
lengthening was identical to that seen in an est2Δ RAD52 background (Figure 4C, 
compare lanes 2- 4 with lanes 5- 7). Therefore, recombination does not contribute to the 
long telomere phenotype.  This result also demonstrates that the mutants reach a new, 
stable telomere length equilibrium and do not undergo continuous elongation. 
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We considered the possibility that the est2-LTE76K allele alters the interaction of 
Est2p with one or more components of the telomerase complex.  Coimmunoprecipitation 
experiments demonstrated that the ability of the ProA-Est2-LTE76K protein to bind HA-
Est1p, HA-Est3p, and Myc-PinXIp was equivalent to wild type (Figure 5), arguing that 
alteration of the relative stoichiometry of these components in the telomerase complex 
does not contribute to the telomere lengthening phenotype. 
To address whether the telomere lengthening phenotype conferred by est2-LTE76K 
is dominant or recessive to wild type, we created a heterozygous diploid strain.  As 
shown in Figure 4D, two independent EST2/est2-LTE76K diploid strains (lanes 3 and 4) 
had telomere length intermediate between that of an EST2/EST2 diploid (lane 1) and an 
est2-LTE76K/est2-LTE76K diploid (lane 2).  Telomere length of the heterozygous diploid 
strain was more heterogeneous than either homozygous diploid strain.  We conclude that 
the est2-LTE76K allele is semi-dominant.  
 
Nucleotide-addition processivity of est2-LT alleles is normal 
The similarity in telomere phenotype between the est2-LT Region I mutants and 
the est2-motifE mutant (Figure 4B) suggested that these alleles might be mechanistically 
related. Increased nucleotide-addition (Type I) processivity demonstrated by the est2-
motifE allele in vitro has been hypothesized to account for increased telomere length in 
vivo 148.  To address whether the est2-LT mutations also increase Type I processivity, 
telomerase was partially purified from yeast cells expressing Protein-A tagged Est2p by 
adsorption to IgG beads.  Bead-bound telomerase was incubated in the presence of 32P-
dGTP, cold dTTP, and a 14 nucleotide telomeric primer.  This oligonucleotide primer 
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Figure 5.  The est2-LTE76K allele does not alter interactions with Est1p, Est3p, or 
PinXIp. 
Strains  pVL288 (HA3-EST1), YKF110 (EST3-HA3) and YKF209 (PINXI-Myc) were 
transformed with pKF404 (untagged EST2; lanes 2, 6, and 10), pKF410 (ProA-EST2; 
lanes 3, 7, and 11), or pKF410-E76K (ProA-est2-LTE76K; lanes 4, 8, and 12).  The 
parental untagged strain (AVL78; MATa leu2 trp1 ura3-52 prb- pre- pep4-3) was 
transformed with pKF404 as an untagged control (lanes 1, 5, and 9).  ProA-Est2p was 
immunoprecipitated on IgG beads as described in Chapter IV and detected with mouse 
monoclonal anti-Protein A (Sigma).  HA3-tagged proteins were detected with monoclonal 
HA.11 antibody (Covance).  PinXI-Myc was detected with monoclonal c-Myc antibody 
(EMD Biosciences).  Secondary was peroxidase-conjugated goat anti-mouse antibody 
(Chemicon International).    
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Figure 6. Processivity of telomerase is increased by a mutation in Motif E, but not by 
mutations in the N-terminal region.  
A. Schematic diagram of the in vitro telomerase assay.  Extension of a 14 nucleotide 
telomeric primer by immunopurified telomerase in the presence of dTTP and 
radiolabeled dGTP results in the addition of up to 7 nucleotides. 
B. Primer extension of the 14 nucleotide primer by wild-type or mutant telomerase.  Extract 
was isolated from strain YKF120 (est2::HIS3) bearing plasmids expressing the indicated  
alleles (ProA-EST2, lanes 1 and 2; ProA-est2-LTE76K, lanes 3 and 4; ProA-est2-motifE, 
lanes 5-8; ProA-est2-LTN95A, lanes 9 and 10) and telomerase was immunopurified on IgG 
beads.  Telomerase assays were performed as described in Chapter IV.  The positions of 
each consecutive nucleotide added to the 14 nucleotide primer are indicated.  +1 marks 
the position of a 14+1 marker created by incubation of the 14 nucleotide primer with 32P 
labeled ddTTP and terminal transferase.  Processivity of the wild-type and mutant 
telomerase was calculated from this and other similar experiments (data not shown) as 
summarized in Table 1. 
Note: This experiment was performed by Katherine Friedman. 
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Table 1.  Processivity values of est2-LT alleles 
 
Strain  Processivity(+3)* (n)  Percent Change#  Significance** 
 
EST2                         0.228 +/- 0.009 (6)   
est2-motifE             0.298 +/- 0.007 (4)   + 31   p≤0.002 
est2-LTN95A         0.229 +/- 0.005 (4)   + 0.4   p≤0.91 
est2-LTE76K         0.216 +/- 0.030 (4)   - 5.0   p≤0.38 
 
 
* Processivity(+3) refers to the frequency with which telomerase synthesizes past the 
third position.  See Chapter IV for details of calculation.  Standard deviation (+/-) is 
indicated as well as the number of independent samples (in parentheses). 
# Percent change of processivity(+3) from wild type is calculated using the average 
values shown in the second column. 
** Significance values were determined relative to wild type using a Student T-test. 
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aligns with the telomerase RNA to allow addition of up to 7 nucleotides in a single round 
of polymerization (Figure 6A). Because yeast telomerase remains bound to its reaction 
products under these conditions 36, the enzyme does not demonstrate repeat-addition 
(Type II) processivity -- the ability to add multiple repeats to a single primer.  Indeed, 
because most primers fail to become extended to the end of the template, a ladder of 
products (+2 to +7) is visualized even after prolonged incubation (Figure 6B).  Because 
the largest effect on processivity was previously shown to occur at the third template 
position 148, nucleotide-addition processivity was expressed as a processivity(+3) value 
[probability that the enzyme extends past the n+3 position; 148] by summing the intensity 
of the last four template positions (n+4 to n+7) and dividing by the total intensity at all 7 
template positions (corrected for specific activity; Chapter IV).  As expected, the est2-
motifE allele showed a significant increase in Type I processivity at the third template 
position (Figure 6B; Table 1).  The percent change in processivity compared to wild type 
(31% increase) was comparable to that previously reported 148, although the absolute 
processivity value for wild-type telomerase was lower in our experiments.  In contrast to 
est2-motifE, the est2-LTN95A and est2-LTE76K alleles had processivity(+3) values 
indistinguishable from wild type (Figure 6B; Table 1).  We conclude that the telomere 
length increase caused by mutations in the N-terminal domain of EST2 differs 
mechanistically from that resulting from mutation in Motif E of the reverse transcriptase 
domain. 
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Primer binding of est2-LT alleles is unaffected  
Recent results suggest that the yeast anchor site lies within Region I of Est2p 33.  Because 
altered primer binding might cause telomere lengthening, we addressed the ability of the 
est2-LT alleles to bind telomeric primer using two independent assays.  The first was a 
primer competition experiment described by Prescott and Blackburn36. Because yeast 
telomerase displays single turn-over kinetics in vitro, a challenge primer added several 
minutes after the initiation of primer extension is not utilized.  This property is 
hypothesized to arise from persistent interactions between the telomerase holoenzyme 
and its reaction products, perhaps mediated by the anchor site.  Indeed, a primer with 
non-telomeric sequence at its 5' end (5' NT primer) is extended normally by telomerase in 
vitro, but fails to block use of the challenge primer 36.  We reasoned that a mutation in the 
telomerase enzyme itself (perhaps in Est2p) that reduces primer interaction might 
similarly increase extension of the challenge primer in this assay.  Both wild-type and 
mutant telomerase were immunopurified from whole cell yeast extract and subjected to 
incubation with one binding as measured in this assay.  Furthermore, because these 
assays were conducted in the presence of all four nucleotides, the failure to detect 
products longer than +7 (Figure 6) indicated that the est2-LT alleles do not cause 
extension past the template boundary. 
 We were concerned that increased primer binding would not be detected in the 
primer competition assay.  Therefore, we also examined the response of wild-type and 
mutant enzyme to decreasing primer concentration.  Telomerase immunopurified from 
EST2 and est2-LTE76K strains was incubated with 5X serial dilutions of a telomeric 14-mer 
primer and 32P-dTTP.  In the absence of dGTP, telomerase adds only a single nucleotide to  
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Figure 7. Yeast telomerase containing a mutation at Est2p residue E76 does not exhibit 
a detectable decrease in product association in a primer-competition assay.   
Extract was isolated from strain YKF120 (est2::HIS3) containing plasmids expressing either 
wild-type, Protein-A tagged EST2 (ProA-EST2, lanes 1-10) or Protein-A tagged est2-LTE76K 
(ProA-est2-LTE76K, lanes 11-13) and telomerase was immunopurified on IgG beads.  Primer 
sequences are shown (Top).  Primers 14 and 29 contain the canonical telomeric sequence, 
while primer 5’NT contains non-telomeric sequence at its 5’ end (underlined). Telomerase 
assays were performed using the indicated combinations of primers (see boxes).  The top 
primer was added at the beginning of the reaction, while the bottom primer (or buffer alone; 
empty box) was added after the reaction had proceeded for seven minutes. Products resulting 
from extension of the 29 nucleotide primer are indicated with brackets.  Lane 1 contains a 
sample that was pretreated with RNase A to eliminate telomerase activity.   
Note: This experiment was performed by Katherine Friedman. 
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the telomeric primer (Figure 8A).  The amount of primer-extension product formed at each 
time point was quantified and normalized using a labeled, 28 nt precipitation and loading 
control.  Wild-type and est2-LTE76K telomerase were indistinguishable in this assay (Figure 
8B and C), showing that the apparent Km for primer in the reaction is not affected by the 
est2-LTE76K allele. 
 We consistently observed a slight (less than two-fold) increase in activity in Est2p 
immunoprecipitates from the est2-LTE76K strain (e.g. Figure 5, compare lanes 1 and 2 with 
lanes 3 and 4).  This increased activity can be attributed to a modest increase in the amount 
of Est2p immunoprecipitated from the mutant strain (Figure 9A).  However, when ProA-
Est2p was detected in extract, expression of the wild-type and Est2-LTE76K proteins was 
equivalent (Figure 9B).  We conclude that the slightly elevated in vitro activity of the mutant 
protein reflects an increased efficiency of immunoprecipitation, rather than increased enzyme 
activity per se.  Although we cannot rule out the contribution of subtle changes in enzyme 
activity, the results presented here suggest that the est2-LT alleles do not alter the intrinsic 
catalytic properties of yeast telomerase.  
 
The est2-LT alleles do not affect the single-stranded character of the telomere 
To explore the possibility that the est2-LT alleles alter telomerase function in vivo, we 
used non-denaturing gel electrophoresis to probe the chromosomal end-structure in wild-
type and mutant strains.  In wild-type cells, yeast chromosomes acquire a long TG1-3 tail 
(more than 30 bp) late in S phase while the 3’ single-strand overhang is <15 bp during the 
remainder of the cell cycle 22.  As a result, DNA isolated from asynchronous wild-type 
cells results in very little telomeric signal when cleaved with XhoI to release a  
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Figure 8. The ability of telomerase to bind primer is unchanged by mutation of Est2p 
residue E76. 
A. Schematic diagram of the in vitro telomerase assay.  Extension of a 14 nucleotide 
telomeric primer by immunopurified telomerase in the presence of radiolabeled TTP 
alone results in the addition of a single nucleotide. 
B. Change in activity of wild-type and mutant telomerase with decreasing primer 
concentration.  Telomerase was partially purified from strain YKF120 (est2::HIS3) 
containing plasmids expressing either wild-type, Protein-A tagged EST2 (ProA-EST2, 
lanes 1-7) or Protein-A tagged est2-LTE76K (ProA-est2-LTE76K, lanes 8-14) by 
incubation with IgG conjugated beads.  Standard telomerase assays were conducted 
(see Chapter IV) at decreasing primer concentrations.  Production of the 14+1 product 
and recovery of a labeled 29 nucleotide precipitation and loading control is shown.  
Primer concentrations are 2.5 µM (lanes 1 and 8), 0.50 µM (lanes 2 and 9), 0.10 µM 
(lanes 3 and 10), 0.02 µM (lanes 4 and 11), 0.004 µM (lanes 5 and 12), and 0.0008 
µM (lanes 6 and 13).  Lanes 7 and 14 are assays done in the absence of primer. 
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C.   Quantification of telomerase activity in response to decreasing primer concentration.  
Band intensities in the experiment shown in Figure 8B and others (data not shown) 
were determined by phosphorimager.  After adjustment for loading and precipitation 
efficiency, values were normalized to activity obtained at the highest primer 
concentration (see Chapter IV for detail).  Primer concentration (log axis) is graphed 
versus average, normalized activity level.  Closed circles, EST2; open circles, est2-
LTE76K.  Error bars represent standard deviation calculated from three independent 
experiments for wild type and two independent experiments for est2-LTE76K. 
Note: This experiment was performed by Katherine Friedman. 
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Figure 9.  Protein expression of wild-type and mutant Est2p is equivalent. 
A. Immunoprecipitation of ProA-Est2p from extract.  ProA-Est2p was 
immunoprecipitated on IgG conjugated beads from strain YKF120 (est2::HIS3) 
containing plasmids expressing either untagged EST2 (pKF404, lane 1), Protein-A 
tagged EST2 (pKF410, lanes 2 and 3) or Protein-A tagged est2-LTE76K (pKF410-Est2-
LTE76K, lanes 3 and 4) and detected by Western blotting using an anti-protein A 
primary antibody. (top band).  Duplicate lanes (2 and 3; 4 and 5) represent two 
independent immunoprecipitations from the same extract preparation to show 
reproducibility.  Supernatants from the immunoprecipitations were Western blotted 
for the presence of Arf1p to verify equivalent extract concentrations (bottom band). 
B. Detection of ProA-Est2p in extract.  Extracts from strain YKF120 (est2::HIS3) 
containing plasmids expressing either untagged EST2 (pKF404, lane 2), Protein-A 
tagged EST2 (pKF410, lane 3) or Protein-A tagged est2-LTE76K (pKF410-Est2-
LTE76K, lane 4) were Western blotted and probed with an anti-protein A primary 
antibody (top band).  Lane 1 contains immunoprecipitated Pro-Est2p (identical to 
Figure 9A, lane 2) as a size marker.  Actin was detected as a loading control (bottom 
band). 
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terminal fragment of 1.3 kb and hybridized under non-denaturing conditions to an 
oligonucleotide that specifically recognizes the G-rich, telomeric 3’ overhang (Figure 
10A, lane 1).  In contrast, a ku70Δ strain has long single-stranded telomeric overhangs that 
persist throughout the cell cycle and are therefore easily detected in asynchronous cells 
[Figure 10A, lane 3; reference 107].  Hybridization in the native gel was specific to single- 
stranded DNA because treatment of the DNA with exonuclease I (ExoI) prior to 
hybridization eliminated the signal (Figure 10A, even numbered lanes). 
Strains expressing the est2-LTN95A, est2-LTE76K, and est2-motifE alleles lacked 
telomeric signal in the native gel (Figure 10A, lanes 5, 7, 9, respectively), indicating no 
increase in single-stranded character compared to the wild-type strain (Figure 10A, lane 
1).  The identical gel shown in Figure 10A was denatured and rehybridized with the 
telomeric oligonucleotide to confirm equivalent loading of the samples (Figure 10B).  We 
conclude that the est2-LT alleles (and est2-motifE) do not significantly compromise 
replication or processing of the C-rich strand of the telomere. 
 
The est2-LT alleles increase telomere length by a TEL1-dependent mechanism, but 
are independent of YKU70, RIF1, and RIF2 
 
 To determine the genetic pathway through which the est2-LT alleles cause 
telomere lengthening, we used epistasis analysis to examine the involvement of several 
genes known to influence telomere length.  The Ku70/80 complex and Tel1p act in 
different pathways to positively regulate telomere length 106.  Therefore, we examined the 
effect of creating double mutations of these genes with the est2-LTE76K allele. 
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Figure 10.  The 3’ single-stranded overhang of est2-LT mutants is normal. 
A. Single-stranded telomeric DNA detected by non-denaturing gel electrophoresis.  All 
strains are derived from YKF120 (est2::HIS3) and carry plasmids expressing wild-
type or mutant Protein A-tagged EST2.  Genomic DNA from strains expressing ProA-
EST2 (lanes 1 and 2), ProA-est2-LTE76K (lanes 6 and 6), ProA-est2-LTN95A (lanes 7 and 
8) or ProA-est2-motifE (lanes 9 and 10) was digested with XhoI, incubated with a 
labeled 22 nucleotide telomeric probe, and subjected to non-denaturing gel 
electrophoresis.  DNA from a ku70 deletion strain previously demonstrated to 
increase the 3’ telomeric overhang 107 was used as a positive control (lanes 3 and 4).  
Samples in lanes 2, 4, 6, 8, and 10 were treated with exonuclease I prior to XhoI 
cleavage to remove the 3’ single-stranded overhang.  The bar indicates the 
approximate position of the terminal XhoI fragment generated from chromosomes 
that contain a subtelomeric Y’ element.  Additional bands detected in lanes 3 and 4 
correspond to individual telomeres lacking the Y’ element. Lane M, end-labeled 
DNA size standards. 
B. Total telomeric DNA detected by hybridization after denaturation. The same gel 
shown in A was denatured by treatment with 0.5M NaOH and hybridized with the 
telomeric probe described in A.  The bar indicates the approximate position of the 
terminal XhoI fragment generated from chromosomes that contain a subtelomeric Y’ 
element.  Although fragments corresponding to the shortest telomeres of the yku70Δ 
strain were preferentially lost during the wash steps, relative loading can be assessed 
by comparison of the higher molecular weight bands. 
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A deletion of yku70 was introduced into strains expressing EST2 or est2-LTE76K.  
Telomere length was assayed by Southern blot after cleavage with PstI.  As shown in 
Figure 11A (lanes 3 and 4), the double mutant strain had telomere length intermediate 
between that of the yku70 deletion alone (lane 5) and the est2-LTE76K single mutant (lane 
2).  Restreaking of the double mutant strain nine times did not result in any further 
change in telomere length (Figure 11A, compare lanes 3 and 4).  Because the telomere 
lengthening phenotype of the est2-LTE76K allele was expressed in the absence of Ku70p, 
we conclude that positive regulation by the Ku70/80 complex contributes little, if at all, 
to the est2-LT phenotype.   
To test the requirement for Tel1p, a tel1::kanMX disruption was introduced into 
strains expressing EST2 or est2-LTE76K.  Two independent est2-LTE76K tel1Δ strains had 
telomeres intermediate in length compared with either single mutant when telomere 
length was assayed immediately after TEL1 disruption (Figure 11B, lanes 3 and 11, 
restreak 1).  However, further propagation of the double mutant strains (to restreak 5) 
resulted in gradual telomere erosion until the double mutant strain attained a telomere 
length nearly as short as that of the tel1Δ strain (Figure 11B, compare lanes 5 and 13 with 
lanes 9 and 17).  Strikingly, both transformants displayed increased heterogeneity of 
telomere length after further restreaking (Figure 11B, lanes 6-8 and 14-16).  In this strain 
background, the est2-LTE76K mutation caused telomere length to increase by nearly 200 
bp compared to wild-type.  In comparison, the tel1Δ est2-LTE76K strain displayed a 
telomere length at restreak 5 that was only 30 bp longer than the tel1Δ strain.  We 
obtained identical results in a tel1Δ est2-LTN95A strain (data not shown).  We conclude  
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Figure 11. Increased telomere length of the est2-LT alleles is dependent on TEL1, 
but independent of YKU70, RIF1, and RIF2. 
A. Epistasis analysis of yku70Δ and est2-LTE76K.  Gene replacement was used to generate 
strains deleted for YKU70 (yku70::KAN) and expressing either wild-type EST2 
(YKF203; lane 5) or est2-LTE76K (YKF203-E76K; lanes 3 and 4) from the 
endogenous, chromosomal locus.  After isolation of the appropriate yku70 disruption, 
the est2-LTE76K yku70::KAN strain was restreaked 9 times to confirm that telomere 
length had stabilized.  DNA isolated after restreak 1 (lane 3) and restreak 9 (lane 4) is 
shown.  Telomere length was visualized by Southern blotting of PstI digested 
genomic DNA with a telomeric probe.  DNA isolated from isogenic YKU70 strains 
expressing wild-type EST2 (YKF201, lanes 1 and 6) or est2-LTE76K (YKF201-E76K, 
lane 2) was included for comparison.  The positions of molecular weight markers are 
indicated (M). 
B. Epistasis analysis of tel1Δ and est2-LTE76K.  Gene replacement was used to generate 
strains deleted for tel1 (tel1::KAN) and expressing either wild-type EST2(YKF202; 
lanes 9 and 17) or est2-LTE76K (YKF202-E76K; lanes 3-8 and lanes 11-16) from the 
endogenous, chromosomal locus.  Because the telomere length phenotype of the tel1Δ 
takes many generations to reach maximum expression, newly transformed strains 
were sequentially restreaked on plates.  For the double mutant, two independent 
transformants were restreaked and DNA was prepared from restreaks 1, 3, 5, 7, 9, and 
10 as indicated.  Only restreak 10 of the tel1Δ strain is shown.  Genomic DNA was 
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digested with PstI, and telomere length was measured by Southern blotting.  DNA 
isolated from isogenic TEL1 strains expressing wild-type EST2 (YKF201, lanes 1 and 
18) or est2-LTE76K (YKF201-E76K, lanes 3 and 10) was included for comparison.  
The positions of molecular weight markers are indicated (M). 
C. Epistasis analysis of rif1Δ and rif2Δ with est2-LTE76K.  Gene replacement was used to 
generate strains deleted for rif2 (rif2::KAN) and expressing either wild-type EST2 
(YKF205; lane 3) or est2-LTE76K (YKF205-E76K; lane 4) from the endogenous, 
chromosomal locus.  Strains deleted for rif1 (rif1::KAN) and expressing wild-type 
EST2 (YKF204; lane 5) or est2-LTE76K (YKF204-E76K; lane 6) from the 
chromosomal locus were also created. Genomic DNA was digested with XhoI, and 
telomere length was measured by Southern blotting.  DNA isolated from isogenic 
RIF1 and RIF2 strains expressing wild-type EST2 (YKF201, lane 1) or est2-LTE76K 
(YKF201-E76K, lane 2) was included for comparison.  The positions of molecular 
weight markers are indicated (M). 
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that telomere lengthening caused by the est2-LTE76K allele is nearly completely dependent 
on Tel1p, though there may be a minor contribution by a Tel1p-independent pathway. 
Tel1p acts downstream of Rap1p in the regulation of telomere length 147.  Therefore, it 
was possible that telomere lengthening in the est2-LT strains occurred through the same 
genetic pathway as RAP1.  Rif1p and Rif2p interact with the C-terminus of Rap1 and 
negatively regulate telomere length 84, 85.  As shown in Figure 11C, rif1Δ and rif2Δ strains 
exhibit increased telomere length compared to a wild-type strain (compare lanes 3 and 5 
with lane 1).  When the est2-LTE76K mutation is combined with a rif1 or rif2 deletion, 
telomere length undergoes an additional increase in each case (Figure 11C, lanes 4 and 
6).  We obtained identical results when double mutants were constructed using the est2-
LTN95A allele (data not shown).  We conclude that the telomere lengthening phenotype of 
the est2-LT alleles is independent of RIF1 and RIF2. 
 
Discussion 
 Telomere length homeostasis is critical to the maintenance of stable 
chromosomes.  Previous work has suggested that telomere length is negatively regulated 
by protein factors that bind to telomeric chromatin [reviewed in reference 17].  
Specifically, Rap1p and its associated proteins bind to the telomeric repeat and regulate a 
molecular switch between telomerase-extendible and non-extendible states 86.  This 
mechanism of telomere length regulation is highly dependent on the chromatin context of 
the telomere, with telomerase presumably acting as a passive downstream target of the 
regulatory pathway.  Here we show that mutations in a small region of the catalytic 
subunit of telomerase also cause telomere lengthening.  Within the limits of our 
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biochemical assays, the catalytic activity of the mutant enzyme is unaffected, indicating 
that the catalytic subunit of telomerase may play a previously unanticipated role in the 
regulation of telomerase activity at the telomere in vivo. 
 
Catalytic activity of the mutant telomerase complex 
The observation that telomeres become overelongated in the est2-LT strains initially 
suggested that telomerase in these strains may have increased or modified catalytic activity.  
Several observations argue against this possibility.  Processivity of the enzyme is not altered, 
a phenotype that has previously been associated with telomere lengthening 148.  Telomere 
lengthening by a defective telomerase enzyme might occur through infidelity of the enzyme 
resulting in abnormal repeat sequences.  Such sequences might disrupt the ability of Rap1p to 
bind the telomere, increasing telomere accessibility.  Although we did not extensively 
analyze nucleotide usage by the mutant complex, there is no detectable synthesis past the +7 
position in our primer-extension analyses, even in the presence of all 4 nucleotides, and no 
change in the electrophoretic mobility of the products, a characteristic that is sensitive to base 
sequence 149.  Furthermore, addition of labeled dTTP alone to the telomerase assay results in 
the addition of a single nucleotide by both mutant and wild-type telomerase, suggesting that 
fidelity at the second template position remains high.  Consistent with these observations, 
est2-LTE76K causes additional telomere lengthening in rif1Δ and rif2Δ strains, implying that 
telomere overelongation is independent of the RAP1 genetic pathway. 
 Est2p can be physically crosslinked to oligonucleotide primer and some mutations 
and deletions within the N-terminus alter primer usage in a manner consistent with loss of the 
telomerase anchor site 33.  Unlike the est2-LT alleles, these mutations cause telomere 
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shortening, suggesting that the est2-LT phenotype does not result from loss of anchor site 
function.  Consistent with this assertion, a primer challenge assay shows no evidence of 
decreased primer association by telomerase in an est2-LT strain.  Telomere lengthening 
might occur if the enzyme-DNA interaction were increased, a possibility consistent with the 
semi-dominant nature of the est2-LTE76K allele.  However, the amount of activity displayed 
by wild-type and est2-LTE76K telomerase on decreasing concentrations of primer is 
indistinguishable, indicating that the Km for primer is not significantly altered by the E76K 
mutation.  We conclude that increased anchor site interaction is unlikely to account for the 
long-telomere phenotype, although we cannot rule out the possibility that slight differences 
in primer association translate into measurable changes in telomere length in vivo. 
 Our experiments show a slight (<2 fold) but reproducible increase in the amount of 
est2-LTE76K mutant protein that can be immunoprecipitated from cells (Figure 9A).  
Interestingly, detection of wild-type and mutant ProA-Est2p in extract demonstrates 
equivalent expression, suggesting that the accessibility of the Protein A epitope tag may be 
altered by the E76K mutation in Est2p.  Because expression of the ProA-Est2-LTE76K protein 
appears unchanged, it is unlikely that differences in protein expression account for the 
telomere lengthening phenotype. 
PinXIp has been shown to compete with the telomerase RNA for Est2p binding 40.  
Therefore, decreased interaction with PinXI might increase telomere length by increasing the 
amount of assembled holoenzyme in vivo.  Consistent with the observation that Region I is 
not required for interaction with PinXIp 40, the ability of PinXIp to bind Est2p is not altered 
by the E76K mutation (Figure 5).  Indeed, although co-overexpression of Est2p and TLC1 
RNA greatly increases the amount of telomerase activity in cell extract, such overexpression 
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does not cause telomere lengthening, presumably because other critical components of the 
complex or telomeric chromatin are limiting 150.  Together with the observation that the 
interaction of Est2p with Est1p and Est3p is not altered by the E76K mutation (Figure 5), 
these data argue that the long telomere phenotype is not due to alterations in the amount or 
stoichiometry of the telomerase complex. 
 
Genetic pathway of telomere lengthening by est2-LT alleles 
 Given the lack of evidence for altered catalytic activity of the est2-LTE76K enzyme, we 
favor the hypothesis that these particular mutations in the N-terminus of Est2p impact a 
regulatory pathway in vivo.  This possibility is supported by the observation that deletion of 
the yeast ATM homolog TEL1 is epistatic to the est2-LT mutants.  Deletion of TEL1 in the 
est2-LTE76K background almost completely abrogates the telomere lengthening phenotype.  
This effect takes 5 restreaks (approximately 125 generations) for full expression and suggests 
that telomerase requires function of the Tel1 protein in order to manifest the est2-LT 
phenotype.  This genetic result distinguishes the est2-LT alleles from mutations in ELG1 98 
and POL12 151 that also cause telomere lengthening, but are independent of TEL1. 
 Tel1p is hypothesized to facilitate the recruitment of telomerase to the telomere in 
vivo by facilitating the interaction between telomerase and its substrate, perhaps through 
modulating activity of the Mre11/Rad50/Xrs2 (MRX) complex 71, 102, 111.  The est2-LT alleles 
may increase the sensitivity of telomerase to this recruitment function.  Because we do not 
detect changes in the interaction between partially purified mutant telomerase and an 
oligonucleotide primer in vitro, we favor the hypothesis that such increased recruitment 
occurs through changes in the interaction between telomerase and components of telomeric 
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chromatin.  Although RIF1 and RIF2 function upstream of TEL1, these genes do not appear 
to play a role in telomere lengthening mediated by the est2-LT alleles since telomere 
lengthening is still apparent in strains completely lacking either RIF1 or RIF2. However, due 
to the redundancy of Rif1p and Rif2p in telomere length regulation, deleting both genes 
would better address whether Rap1p/Rif1p/Rif2p complex is involved in generating the LT 
phenotype, which is discussed in Chapter III. 
 Interestingly, in two independent est2-LTE76K tel1Δ transformants (and in est2-LTN95A 
tel1Δ strains, data not shown), we observed increased heterogeneity of the telomeric repeats 
at long generation times, though the minimal telomere length remained approximately the 
same.  This phenomenon suggests that the est2-LT alleles can cause telomere lengthening 
through an alternative pathway that is either selected after long-term growth or becomes 
activated when telomere length is sufficiently short.  This alternate pathway may account for 
the slight (~30 bp) TEL1-independent increase in telomere length seen at moderate 
generation times. 
 Because only a small fraction of yeast telomeres are subject to the activity of 
telomerase in a given cell cycle 86, we suggest that the est2-LT alleles alter either the 
frequency with which telomerase engages the telomere, or the extent of polymerization once 
a telomere has been "chosen" for elongation.  The increased telomere length heterogeneity of 
a diploid strain expressing both wild-type and mutant telomerase presumably reflects 
competition for telomere access between telomerase complexes that are correctly regulated, 
and those that are at least partially refractory to that regulation.  Future experiments to 
distinguish these possibilities may clarify the mechanism through which the est2-LT alleles 
 59 
cause telomere lengthening and uncover a novel role of the telomerase enzyme in telomere 
length regulation. 
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CHAPTER III 
 
IDENTIFICATION OF PHENOTYPIC CONSEQUENCES OF est2-LT IN VIVO 
 
Work described in this chapter is mostly included in the following manuscript: 
Hong Ji, Christopher J. Adkins, Bethany R. Cartwright, and Katherine L. Friedman  
Yeast Est2p affects telomere length by influencing association of Rap1p with telomeric 
chromatin.  
 
Abstract 
In Saccharomyces cerevisiae, sequence-specific binding of the negative-regulator Rap1p 
provides a mechanism to “measure” telomere length: as telomere length increases, 
binding of additional Rap1p inhibits telomerase activity in cis. We provide evidence that 
the association of Rap1p with telomeric DNA in vivo occurs in part by sequence-
independent mechanisms. Specific mutations in EST2 (est2-LT) reduce the association of 
Rap1p with telomeric DNA in vivo. As a result, telomeres are abnormally long, yet bind 
an amount of Rap1p equivalent to that observed at wild-type telomeres. This behavior 
contrasts with a second mutation in EST2 (est2-up34) that increases bound Rap1p as 
expected for a strain with long telomeres. Telomere sequences are subtly altered in est2-
LT strains, but similar changes in est2-up34 telomeres suggest that sequence 
abnormalities are a consequence, not a cause, of over-elongation. Indeed, est2-LT 
telomeres bind Rap1p indistinguishably from wild type in vitro. Taken together, these 
results suggest that Est2p can directly or indirectly influence the binding of Rap1p to 
telomeric DNA, implicating telomerase in roles both upstream and downstream of Rap1p 
in telomere length homeostasis. 
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Introduction 
Telomeres are nucleoprotein structures that protect chromosome ends from 
nucleolytic digestion and preclude recognition of normal ends as double strand breaks 
(DSB; 1). In most eukaryotes, telomeres are maintained by telomerase, a 
ribonucleoprotein that uses a short region of its RNA subunit as a template for reverse 
transcription. In Saccharomyces cerevisiae, a reverse transcriptase (EST2) and RNA 
subunit (TLC1) form the catalytic core of telomerase 28, 45, 128. Est2p contains at least three 
functional domains: an N-terminal “TEN” domain that anchors Est2p on its DNA 
substrate 33, 37 and may interact with other protein components 50, an RBD region that 
binds TLC1 RNA and contributes to dimerization 40, and a reverse transcriptase (RT) 
domain conserved among other telomerases and viral RTs 128. 
While many organisms synthesize perfect TG-rich telomeric repeats, several 
protozoa, fungi, slime molds and plants have heterogeneous telomere sequences 125. 
Among these, Sacchromyces cerevisiae and Schizosaccharomyces pombe have the most 
profound degeneracy, with telomeric consensus sequences of 5’-[(TG)0-
6TGGGTGTG(G)]n 14and 5’-[GGTTACAG0-4]n152, respectively. Several models have 
been proposed to explain this heterogeneity. Analysis of wild-type (WT) telomeres and 
telomeres generated in the presence of template mutations suggests that registration of the 
telomere terminus occurs preferentially at the 3’ end of the template, with processive 
synthesis through a central “core” region and decreasing processivity at the 5’ end of the 
template 14, 153. In contrast, telomere junction fragments generated during chromosome 
healing events are more consistent with non-processive synthesis and patterning driven 
by substrate/template alignment 154. In “humanized” yeast cells in which the yeast RNA 
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template is substituted with that of human, Est2p generates perfect hexanucleotide 
repeats, suggesting that template sequence can influence template usage 155. 
 In S. cerevisiae, normal telomere length varies between 225 and 375bp 156. The 
primary negative regulator of telomere length is Rap1p, a protein that associates directly 
with duplex telomeric DNA on average every 18bp 157. Artificially targeting Rap1p to an 
individual telomere proportionately shortens the TG1-3 tract in cis 2. This negative 
regulation requires Rif1p and Rif2p, proteins that bind to the C-terminus of Rap1p and 
play overlapping, but not fully redundant, roles in telomere length homeostasis 84, 85, 145. 
Deletion of RIF1 or RIF2 increases the frequency of telomere elongation during a single 
cell cycle, suggesting that the Rap1p/Rif1p/Rif2p complex modulates telomerase access 
in a manner responsive to telomere length 86. Rap1p also mediates silencing of genes near 
telomeres and has been implicated in the repression of non-homologous end joining and 
telomere resection near a DSB 115, 158, 159. 
We previously reported mutations (est2-LT alleles) in the Est2p TEN domain that 
cause telomere over-lengthening by an unknown mechanism 160. Here, we demonstrate 
that est2-LT strains do not increase telomeric Rap1p association or gene silencing as 
observed upon telomere over-elongation in other genetic backgrounds. The est2-LT 
phenotype is suppressed when Rap1p length regulation is compromised, indicating that 
the decreased binding of Rap1p per nucleotide within est2-LT telomeres causes telomere 
over-elongation. Although telomere sequences are altered in est2-LT strains, the 
association of Rap1p with these sequences is not detectably changed in vitro. Indeed, the 
same sequence alterations occur in est2-LT strains that increase telomere length by other 
mechanisms. Taken together, these data provide evidence that a subset of residues in the 
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catalytic subunit of S. cerevisiae telomerase modulate the association of Rap1p with 
telomeric DNA in vivo in a sequence-independent manner, thereby affecting the extent of 
telomere elongation.  
 
Results 
Rap1p association with est2-LT telomeres does not correlate with telomere length 
The est2-up alleles were identified in a screen for mutations of EST2 that improve 
transcriptional silencing of a telomere-proximal gene 90. Increased telomere length is 
thought to mediate this phenotype by increasing Rap1p association and subsequent 
recruitment of the histone deacetylase Sir2p 115. Given that the entire EST2 open-reading 
frame was subjected to mutagenesis, we were surprised that this screen failed to identify 
mutations in the EST2 TEN domain. We speculated that est2-LT strains, despite 
containing longer-than-normal telomeres, might not increase telomeric silencing. Two 
representative est2-LT alleles were chosen for analysis: est2-LTE76K (glutamic acid 76 to 
lysine) and est2-LTN95A (asparagine 95 to alanine). est2-LTE76K causes telomere length to 
increase by ~100 bp, while est2-LTN95A has a slightly smaller, but reproducible effect 
(Figure 12B, lanes 2 and 3, respectively). 
 To assay telomeric gene silencing, plasmid-borne EST2 alleles were introduced to 
an est2Δade2Δ strain with ADE2 inserted near the right telomere of chromosome V 
(Figure 12C). Cells expressing WT EST2 grow well on plates lacking adenine and are 
predominantly white, with small red sectors indicative of moderate ADE2 silencing 
(Figure 12C). Consistent with the previous report, est2-up34 [the strongest est2–up allele 
(D460N)] increases telomeric silencing, as indicated by the formation of red colonies 
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with reduced growth in the absence of adenine. In contrast, telomeric silencing in cells 
expressing est2-LTE76K, est2-LTN95A, or est2-motifE is indistinguishable from WT (Figure 
12C). The difference in silencing behavior of the mutant strains cannot be attributed to 
differences in telomere length, since all over-lengthen telomeres to a similar extent 
(Figure 12B). We conclude that telomere over-lengthening in est2-LT and est2-motifE 
strains is not accompanied by increased telomeric silencing. 
 Given that the est2-up and est2-LT mutations differentially affect telomeric 
silencing and are located in distinct regions of the Est2 protein, we hypothesized that 
these alleles increase telomere length through distinct mechanisms. To test this 
hypothesis, we monitored a genetic interaction previously reported for the est2-up alleles. 
In a strain lacking the Pif1 helicase, a negative-regulator of telomere length, est2-up34 
does not cause any additional telomere lengthening 90. This result, combined with 
biochemical evidence, suggests that mutations in the finger subdomain (including est2-
up34) render telomerase at least partially resistant to negative regulation by Pif1p 90. To 
test if other est2 alleles behave similarly, we created a pif1Δest2Δ strain expressing 
plasmid-borne WT or mutant alleles of EST2. As shown in Figure 12D, only est2-up34 
fails to cause additional telomere lengthening in this background.  We conclude that est2-
LT and est2-motifE lengthen telomeres by a mechanism distinct from that of est2-up34. 
Since Rap1p is required for telomeric silencing, our observation that increased telomere 
length is not always accompanied by increased gene silencing suggested that the longer 
telomeres of the est2-LT and est2-motifE strains might not undergo the expected increase 
in total Rap1p association. Chromatin immunoprecipitation (ChIP) was used to address  
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Figure 12. Strains expressing different telomere-lengthening alleles of EST2 have 
distinguishable phenotypes. 
A. Locations of long-telomere mutations within EST2. Domain structure of Est2p is 
shown 161. Mutations in three distinct regions cause longer-than-normal telomeres: 
est2-LT in the TEN domain, est2-up in motifs 1 and 2, and est2-MotifE in the RT 
domain 90, 148, 160.  The est2-up34 allele utilized in this study (D460N) is indicated 
with an asterisk. 
B.    Telomere length in est2 strains. Genomic DNA from the indicated strains was 
cleaved with XhoI, separated in a 1.2% agarose gel, Southern blotted, and probed 
with a telomeric DNA fragment. Strains shown are identical to those used for the 
silencing (Fig. 12C) and ChIP assays (Figure 13). M=DNA size marker. 
C. Expression of a telomere-proximal ADE2 gene in est2 strains. Telomeric silencing 
was tested in an est2Δade2Δ strain containing an ectopic copy of ADE2 inserted near 
the right telomere of chromosome V (diagram, top). This strain (YKF501) was 
transformed with a URA3 plasmid expressing the indicated EST2 allele. Shown are 
10X serial dilutions of cells grown on media lacking uracil or lacking uracil and 
adenine, ~75 generations after introduction of the complementing plasmids. 
D. Dependency of est2-mediated telomere over-elongation on PIF1. Strains of genotype 
est2Δ (YKF501) or est2Δpif1Δ (YKF503) were transformed with URA3 plasmids 
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expressing WT EST2 (lanes 1-3, 10) or the indicated est2 allele. Cells were grown 
~75 generations to allow telomere length to stabilize. Genomic DNA isolated from 
the indicated strains was digested with XhoI, Southern blotted, and probed with 
telomeric DNA. Telomeres containing a subtelomeric Y’ element are shown. 
M=DNA size marker. 
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Figure 13. Association of Rap1p with WT and mutant telomeres correlates with 
telomeric silencing, but not with telomere length. 
A. Association of Rap1p with WT and mutant telomeres. Chromatin 
immunoprecipitation was used to measure the association of Rap1p with telomeric 
DNA. Values represent the fraction of total telomeric DNA immunoprecipitated with 
anti-Rap1p antibody, normalized to WT in each independent experiment. Error bars 
represent standard deviation of at least three experiments. A paired T test was used 
to determine significance. P values are indicated (brackets) only for those samples 
that differ significantly from WT (p<0.05). (Left and center panels) Analysis of 
strains in the YKF501 (GA426 est2Δ::TRP1) background. The indicated ProA-EST2 
alleles (WT, est2-LTE76K, est2-motifE, est2-up34, and est2-LTN95A) were expressed 
from plasmid pKF410. Strains are identical to those utilized in Figure 1B and C. 
(Right panel) Analysis of strains in the GA426 background: GA426 (WT), YKF500 
(GA426 with est2-LTE76K integrated at the endogenous locus), and YKF502 (GA426 
rif2Δ::TRP1). 
B. Measurement of relative telomeric DNA abundance. Telomeric DNA abundance was 
quantified in input extracts from the identical samples shown in A. by measuring the 
ratio of signal generated with a telomeric DNA probe to that of a single-copy 
sequence (372-bp fragment of ARO1). Values were normalized to WT in each 
independent experiment. Error bars represent standard deviation of at least three 
experiments. A paired T test was used to determine significance. P values are 
indicated (brackets) for those samples that differ significantly from WT (p<0.05). 
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this possibility. To keep most telomeres intact, formaldehyde-crosslinked chromatin was 
sheared by sonication to 500-1000bp. Rap1p was immunoprecipitated and associated 
telomeric DNA was quantified by hybridization. To account for differences in telomere 
length, we expressed the amount of precipitated fragment as a percent of input telomeric 
DNA.  Under these conditions, the efficiency of immunoprecipitation is proportional to 
the amount of Rap1p bound to each telomere. Values were normalized to those of a WT 
sample processed in parallel. 
  As predicted by the lack of increased telomeric silencing, the association of 
Rap1p with telomeres in est2-LTE76K, est2-LTN95A, and est2-motifE strains is 
indistinguishable from WT (Figure 13A). In contrast, expression of est2-up34 
significantly increases the efficiency of telomeric DNA immunoprecipitation by Rap1p 
(Figure 13A). To rule out the possibility that est2-up34 abnormally increases Rap1p 
association, we monitored a control strain (rif2Δ) in which the extent of telomere over-
elongation is similar to that observed in est2-LTE76K and est2-up34 (see below). As 
expected from Rif2p’s role downstream of Rap1p 85, the elongated telomeres of a rif2Δ 
strain bind significantly more Rap1p than WT (Figure 13A). 
 To confirm that differences in Rap1p association cannot be attributed to 
differences in the extent of telomere over-elongation, we measured the ratio of 
hybridization of a telomere-specific probe to that of a single-copy control sequence 
(ARO1) in input samples from each strain. While the relative abundance of telomeric 
DNA was significantly increased over WT, the extent of telomere over-elongation in the 
different mutant strains was statistically indistinguishable (Figure 13B). The observation 
that the longer telomeres of est2-LTE76K, est2-LTN95A and est2-motifE strains bind no more 
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Rap1p than WT length telomeres is consistent with an overall reduction (per nucleotide) 
in the association of Rap1p within telomeres in these mutant strains. This result led us to 
address the role of Rap1p in generation of the long-telomere phenotype. 
 
Generation of the long-telomere phenotype in est2-LT strains requires the association 
of Rap1p with telomeric DNA 
 
Since telomere elongation is inhibited in a manner proportional to the amount of bound 
Rap1p, a reduction in the frequency of Rap1p association with telomeres should cause 
telomere over-elongation (as previously observed for certain mutations in the telomerase 
template;162.  An equilibrium length is reached when telomeres bind, on average, an 
amount of Rap1p equivalent to that normally associated with WT telomeres. The 
observation that transcriptional silencing and total Rap1p association at the elongated 
telomeres of est2-LT and est2-motifE strains is equivalent to WT fits this prediction and 
suggests that telomere over-lengthening is a response to reduced binding by Rap1p. If 
true, telomere over-elongation in est2-LT strains should be Rap1p-dependent. 
We initially set out to eliminate Rap1p function by deleting its binding partners, 
Rif1p and Rif2p. Unfortunately, the extreme length and heterogeneity of telomeres in this 
background made it impossible to determine if the est2 alleles cause additional elongation 
(data not shown). To circumvent this difficulty, we took advantage of a strain in which 
the yeast RNA template is replaced with that of the human telomerase RNA, dictating 
synthesis of the hexanucleotide sequence (5’-TTAGGG) normally found at human 
telomeres 155. This “humanized” sequence does not bind Rap1p, but telomeres are short 
and stable due to an alternate, Tbf1p-dependent mechanism 104, 163, 164. An est2Δ strain 
expressing the humanized TLC1 variant (tlc1-human) from its endogenous locus was 
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grown for approximately 50 generations in the absence of telomerase to allow telomere 
shortening. This strain was subsequently transformed with plasmids expressing WT or 
mutant est2, and telomerase was allowed to synthesize telomeres in the presence of the 
humanized RNA. Although the internal telomeric sequences in these strains retain wild-
type sequence and are capable of binding Rap1p, any additional DNA synthesized by the 
mutant enzymes is derived from the humanized template. As one would predict for 
mutations dependent on Rap1p, neither est2-LTN95A nor est2-LTE76K increase telomere 
length compared to WT when utilizing the humanized RNA (Figure 14A and B). In 
contrast, est2-up34 retains the ability to cause telomere over-lengthening in this 
background, consistent with a Rap1p-independent mode of action (Figure 14C). 
Surprisingly, est2-motifE also over-elongates telomeres in this background (Figure 14A, 
lanes 12-15).  Telomeres cloned from the est2-LTE76K and est2-motifE strains contain 
perfect six-nucleotide repeats at the chromosome terminus (data not shown), confirming 
that Rap1p binding is eliminated within the newly synthesized sequences. The failure of 
est2-LTE76K and est2-LTN95A to lengthen telomeres in the humanized background suggests 
that telomere lengthening occurs in response to the reduced frequency of telomeric Rap1p 
association in vivo, although we cannot eliminate the possibility that altering the template 
sequence has other unanticipated effects on the est2-LT phenotype. We also conclude that 
est2-motifE affects telomere length in a manner that is at least partially Rap1p-
independent. 
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Figure 14. Telomere over-lengthening by the est2-LT alleles is suppressed in a 
background of “humanized” TLC1. 
A. est2Δ strains expressing WT TLC1 (lanes 1-3) or a tlc1-human variant (lanes 4-15) 
were transformed with plasmids bearing EST2, est2-LTE76K, or est2-motifE as 
indicated. DNA was cleaved with PstI, separated in a 1.5% agarose gel, Southern 
blotted, and probed with a mixture of two DNA fragments [S. cerevisiae telomere 
DNA and “humanized” (TTAGGG)n sequence]. M=DNA size marker. 
B. est2Δ strains expressing WT TLC1 (lanes 1 and 2) or a tlc1-human variant (lanes 3-
10) were transformed with plasmids bearing EST2 or est2-LTN95A as indicated.  
Samples were treated as described in A. 
C.    est2Δ strains expressing a tlc1-human variant were transformed with plasmids      
  bearing EST2 or est2-up34 as indicated.  Samples were treated as described in A. 
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Telomere over-elongation is associated with altered telomere sequences in vivo 
We sought to understand the mechanism through which the frequency of Rap1p 
association is decreased at est2-LT telomeres. Given that Rap1p associates directly with 
telomeric DNA, altering the sequence of the telomeric repeat could have this effect. To 
examine this possibility, telomere sequences were obtained in two ways that allowed 
unambiguous identification of repeats synthesized by the mutant enzyme. In a multi-cell 
cycle analysis, telomeres were allowed to shorten for ~50 generations in the absence of 
EST2. WT or mutant EST2 was introduced, telomere length was recovered for ~75 
generations, and multiple clonal isolates of a single telomere were sequenced 14. Because 
yeast telomerase generates irregular sequences, repeats synthesized after introduction of 
the complementing plasmid were identified by their divergence from the identical, 
internal repeats. In a second approach (Single Telomere Extension assay, or STEX), 
telomere repeats generated during a single S phase were analyzed 86. est2Δ recipient cells 
with shortened telomeres were mated with donor cells expressing EST2 or est2-LTE76K at 
the endogenous locus. After zygotes proceeded through the first post-zygotic S phase, 
marked telomeres originating in the recipient strain were cloned and sequenced. Again, 
newly synthesized repeats were identified as those sequences that did not align between 
different telomeres. The frequency and extent of telomere elongation by est2-LTE76K 
telomerase during a single S phase were not statistically different from WT, with a 
marked preference for elongation of the shortest telomeres, as previously reported (Figure 
15; ref. 86). 
 Detailed inspection of est2-LTE76K telomeres did indeed reveal a change in 
telomere sequence. As previously described, approximately 90% of repeats in WT 
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Figure 15. Analysis of telomere addition in a single cell cycle. 
An est2Δ recipient strain was mated with strains expressing either wild-type EST2 
(center) or est2-LTE76K (right). Telomeres were cloned and sequenced after completion of 
the first post-zygotic S phase. Lengths of individual telomeres are plotted. For each 
telomere, identical TG1-3 sequences resulting from semi-conservative DNA replication 
(gray) and divergent sequences representing new telomere addition (black) are shown. 
Based on the low frequency of telomere addition in the absence of mating (left) and on 
observed significant differences in telomere sequence following mating to EST2 or est2-
LTE76K donors (Table 4), we infer that most divergent sequences result from telomere 
extension by telomerase. The average amount of new telomere addition is 82 nt (EST2) 
and 58 nt (est2-LTE76K). These differences are not statistically significant (p=0.084; 
nonparametric Kruskal-Wallis test). Likewise, the frequency of telomere addition is 
statistically indistinguishable between the two strains (p=0.09, Fisher’s exact test). 
Telomeres utilized for experiments shown in Figures 17 and 18 are indicated (*).  
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Table 2. Comparison of telomere sequences added by WT and mutant telomerase. 
Percent of GG dinucleotide incorporation (values)a 
 
Wild Type est2-LTE76K est2-LTN95A est2-motifE est2-up34 
Multi-cell cycle 52.5 (31/59) 67.1 (53/79) 63.6 (35/55) 64.9 (37/57) 65.1% (56/86) 
Single cell cycle 56.6 (43/76) 77.3 (51/66)b 
Telomere healing  63.5% (54/85) 66.2% (43/65) 
a Calculated as the percent of total core sequences that are followed by GG dinucleotide 
(see Chapter IV). 
b The difference between WT and est2-LTE76K telomeres is significant using a Fisher’s 
Exact Test (p=0.012). 
 
Percent of overlapping core sequences (values)c 
 
Wild Type est2-LTE76K est2-LTN95A est2-motifE est2-up34 
Multi-cell cycle 29.2 (14/48) 17.5 (11/63) 20.5 (9/44) 14.5 (8/55) 15.6 (12/77) 
Single cell cycle 27.7 (18/65) 12.7 (7/55)d 
Telomere healing 22.1 (18/81) 19.4 (12/62) 
 
c Calculated as the percent of overlapping core sequence event (Chapter IV).   
d Fisher’s Exact Test was used to compare the difference between WT and est2-LTE76K 
telomeres (p=0.07). 
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Figure 16.  The pattern of telomere-repeat addition is altered in est2-LTE76K strains. 
 A. Model of yeast telomere-repeat heterogeneity 14. Processive reverse transcription 
(RT) of a central portion of the telomerase template RNA (gray) incorporates the 5’-
TGGGTGT “core sequence” in ~90% of repeats. Heterogeneity is proposed to arise 
from a combination of poor processivity (gray nucleotides) and multiple registers of 
alignment and abortive RT at the 3’ end of the template. The GG-dinucleotide is 
produced by RT of 470CC471 (box). 
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 B. The number of nucleotides between core sequences is significantly altered in est2-
LTE76K telomeres. The number of nucleotides between core sequences (5’-
TGGGTGT) was graphed from WT and est2-LTE76K telomeres synthesized during a 
single cell cycle. “-1” spacing occurs when the 3’ T of one core sequence is identical 
to the 5’ T of the next. Data derive from 65 WT repeats and 55 mutant repeats. 
Distributions of absolute values are statistically different (p<0.02) by the Chi-square 
contingency test. 
 C. The majority of predicted Rap1p binding sites overlap. Rap1p sites predicted within 
a representative WT sequence (see Chapter IV) are underlined.  Overlap is indicated 
by negative values (parentheses). 
 D. Predicted Rap1p binding sites are more dispersed in est2-LTE76K telomeres than in 
WT telomeres. The amount of overlap between 31 predicted Rap1p binding sites in 
WT telomeres and 31 sites in est2-LTE76K telomeres was determined using the 
method illustrated in C and the frequency of each class was plotted. Distances of 
greater than 2 nucleotides were grouped. Distributions of absolute values are 
statistically different (p=0.042) by the Chi-square contingency test. 
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telomeres contain a 7-nucleotide “core sequence” (5’-TGGGTGT; Figure 16A), half of 
which are followed by two consecutive Gs (as templated by TLC1; ref. 14). est2-LTE76K 
telomeres contain this GG dinucleotide at increased frequency (67-77%; Table 2). A 
combined probability test examining the magnitude of the effect in telomeres generated 
by both experimental regimes indicates statistical significance (p=0.025; ref. 165). 
While the majority of core sequences in WT telomeres are separated by 2 or more 
nucleotides, nearly 30% overlap to generate the sequence 5’-TGGGTGTGGGTGT (a 
spacing of “-1”). Telomeres synthesized in a single cell cycle by Est2-LTE76Kp show a 
greater than 50% reduction in the ”-1” spacer class (Table 2) and an overall shift in the 
distribution of spacer lengths (Figure 16B; p=0.03). This is the first reported example of a 
mutation within the yeast catalytic subunit that affects the patterning of telomere repeats 
in vivo. 
To address potential impact on Rap1p binding, a computer algorithm 
(MatInspector) was used to identify putative Rap1p sites in WT and mutant sequences 166. 
As previously described, nearly all predicted Rap1p binding sites fall into three classes 
corresponding to 13/13, 12/13, and 11/13 matches to the consensus sequence 153. est2-
LTE76K telomeres shift the distribution among these classes, with a relative paucity of the 
5’-TGGGTGTGGGTGTG sequence (11/13 match) reflecting the reduction in 
overlapping core sequences (Table 3). In addition, the extent of overlap between adjacent 
predicted Rap1p sites is reduced in est2-LTE76K telomeres (Figure 16C and D; p=0.042). 
This effect is small and does not decrease the total number of predicted sites over the 
length of a telomere. However, we speculated that changing the relative spacing of 
adjacent sites might disproportionately affect Rap1p occupancy. 
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Table 3. Predicted Rap1p binding sites in wild type, est2-LTE76K and est2-LTN95A 
telomeres. 
a Rounded to one decimal place. The percentages do not sum to 100% in some cases due 
to rounding. 
b est2-LTN95A has one site with the sequence of  TGTGTGTGGGTGG (11/13 match, 
matrix similarity 0.858) that is rarely present in vivo. 
Note: Wild-type and est2-LTE76K telomeric sequences are from single cell cycle 
experiments and est2-LTN95A sequences are from multi-cell cycle experiments.  
Percent occurrence (values)a 
 Rap1p sites 
 
Matrix 
similarity 
Match to 
13bp 
consensus Wild Type est2-LTE76K est2-LTN95A(b) 
GGTGTGTGGGTGTG 
TGTGTGTGGGTGTG 
TGGGTGTGGGTGTG 
GTGGTGTGGGTGTG 
0.902 
0.901 
0.806 
0.795 
13 
12 
11 
11 
40.0 (14/35) 
17.1 (6/35) 
25.7 (9/35) 
17.1(6/35) 
47.2 (17/36) 
36.1 (13/36) 
11.1 (4/36) 
5.6 (2/36) 
31.7 (13/41) 
26.8 (11/41) 
17.0 (7/41) 
21.9 (9/41) 
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We reasoned that if the sequence alterations observed in est2-LTE76K telomeres 
directly account for the reduced frequency of Rap1p binding (Fig. 13A), similar changes 
should be observed in other strains that exhibit this phenotype (est2-LTN95A and est2-
motifE). Indeed, sequencing of telomeres generated in both strains over multiple 
generations reveals sequence changes reminiscent of those observed in est2-LTE76K (Table 
2), with similar changes in the distribution of predicted Rap1p binding sites (data not 
shown). As a control, we examined telomere sequences from the est2-up34 strain. Since 
Rap1p binding is increased at est2-up34 telomeres in vivo (Figure 13A), we predicted no 
change in telomere sequence. Contrary to our expectation, est2-up34 telomeres also 
display increased GG-dinucleotide frequency and reduced core sequence overlap 
compared with WT.  Indeed, the telomere sequence changes among the four mutant  
strains are statistically indistinguishable (Table 2; p=0.98 and 0.87) when comparing GG 
incorporation and overlapping core sequences, respectively, in a 2x4 Chi-square 
contingency test). Given that changes in telomere sequence do not correlate with the 
extent of Rap1p binding in vivo, we conclude that altered telomere patterning is a 
consequence, rather than a cause, of telomere over-elongation in these mechanistically 
distinct est2 strains. 
 
Rap1p association at WT and est2-LTE76K telomeres is indistinguishable in vitro 
Although telomere sequence alterations do not appear directly responsible for reduced 
Rap1p binding in vivo, we wanted to determine the consequence of the predicted changes 
in Rap1p binding sites observed at est2-LTE76K telomeres.  To address whether these 
altered sequences reduce Rap1p association, we assayed binding of recombinant Rap1p 
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to cloned WT and mutant telomeres in vitro. Matched WT and mutant clones containing 
approximately the same amount of telomeric DNA (~230bp or ~180bp) were chosen 
from the STEX experiment (Figure 15, telomeres marked with asterisk). In the mutant 
telomeres, 91% (E184) or 48% (E229) of the total TG1-3 sequence was synthesized by 
est2-LTE76K telomerase. In general, sequences on these telomeres are representative of the 
overall trend of increased GG-dinucleotide incorporation and decreased core sequence 
overlap observed among all est2-LTE76K telomeres (Figure 17A). The variability in GG-
dinucleotide rate observed in the WT telomere sequences reflects stochastic variation 
given the small number of repeats in each clone. Consistent with the relatively small 
change in overlap between predicted Rap1p binding sites that we observe among all 
mutant telomeres (Figure 16C and D), the total number of predicted Rap1p binding sites 
is similar between size-matched WT and est2-LTE76K telomere clones (Figure 17A). 
 To address the occupancy of predicted Rap1p sites, we monitored binding of full-
length, recombinant Rap1p to WT and est2-LTE76K-derived sequences by DNaseI 
footprinting. In all four telomeres, regions of protection correspond well with prediction 
(Figure 17B). Strong protection observed on est2-LTE76K telomeres suggests that the 
majority of substrates are bound, arguing against a substantial decrease in binding 
efficiency. 
 To quantify Rap1p association more carefully, we measured the ability of the 
size-matched WT and est2-LTE76K telomeres to compete for Rap1p binding to a short 
double-stranded substrate by gel shift. Unlabeled telomeric competitor DNA 
quantitatively reduces the association of Rap1p with the radiolabeled substrate (Figure 
18A). Because each unlabeled DNA contains 14-17 potential Rap1p binding sites (Figure 
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Figure 17. est2-LTE76K telomeres bind Rap1p at predicted sites in vitro. 
 A. The characteristics of four cloned telomere fragments utilized in Figure 17B and 
Figure 18 are shown. Two WT telomeres (W239 and W178) and two est2-LTE76K 
telomeres (E229 and E184) were generated by telomere addition in a single cell 
cycle. Numbers indicate the length of TG1-3 repeat. In est2-LTE76K telomeres, only a 
portion of this sequence is generated by the mutant enzyme (91% for E184 and 48% 
for E229). The percent of core sequences followed by “GG”, percent of overlapping 
core sequences, and number of predicted Rap1p binding sites (see Chapter IV) are 
determined for the entire TG1-3 sequence. Each DNA fragment also contains ~100bp 
of identical sub-telomeric and vector-derived sequences. 
 B.   DNaseI footprinting analysis of Rap1p bound to telomeric substrates. Rap1p (20 fold 
molar excess) was bound to 100 fmoles of 32P-end labeled telomeric DNA (W239, 
W178, E229, or E184 as indicated) prior to DNase I treatment. Control reactions (0) 
were incubated in the absence of Rap1p. A black bar indicates a 13/13 or 12/13 
match to the Rap1p consensus sequence and a gray bar indicates an 11/13 match (see 
Chapter IV and Table 3). Not all Rap1p sites are shown due to poor resolution near 
the top of the gel. For E229 and E184, the transition between sequences synthesized 
by est2-LTE76K telomerase (at the labeled end of the DNA molecule) and WT 
telomerase is indicated (arrow). 
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Figure 18. Association of Rap1p with est2-LTE76K telomeres is not reduced in vitro. 
A. Increasing amounts (0, 5, 10, 20, 30, 50, 60, 80 fmoles) of WT (W239) unlabeled 
telomeric DNA were mixed with 100 fmoles of an 18bp 32P-labeled double-stranded 
DNA and 400 fmoles of recombinant Rap1p. Binding reactions were separated by 
polyacrylamide gel electrophoresis and visualized by phosphorimager. 
B. Quantification of multiple experiments performed as in (A) using WT (W239 and 
W178) or mutant (E229 and E184) competitor DNAs. “% competition” was 
calculated by normalizing the fraction of oligonucleotide bound to Rap1p in each 
sample to the value observed in the absence of competitor. Error bars represent 
standard deviation from three independent experiments. 
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17A), effective competition occurs at low molar ratios. This assay is quite sensitive, as 
we could distinguish two WT telomere sequences differing by less than 30% in length 
(239bp versus 178bp; Figure 18B). The ability of the longer sequence to compete nearly 
half of the binding to the short oligonucleotide at a 1/20 molar ratio is consistent with the 
16 predicted Rap1p sites on this fragment. est2-LTE76K telomeres compete at least as well 
for Rap1p binding as their size-matched controls. For example, at the 1/20 molar ratio, 
est2-LTE76K and WT telomeres of ~180bp reduce the shifted product by 25.5 +/- 1.5% and 
18.9 +/- 10.2%, respectively. The longer est2-LTE76K telomere (E229) competes even 
better than its WT counterpart, perhaps reflecting the additional Rap1p site predicted 
within this sequence (Figure 17A). We conclude that changes in telomere sequence 
cannot account for the reduced frequency with which Rap1p associates with est-2LT 
telomeres in vivo. 
 
A mutation in the N-terminus of SpTrt1p causes telomere overelongation and alters 
telomere sequences in vivo. 
 
To determine whether the est2-LT region plays a similar role in another organism 
that has heterogeneous telomere sequences, several mutations were made in the N-
terminal region of S. pombe TERT based on sequence homology (Figure 19A).  A strain 
lacking endogenous trt1+ was transformed with plasmids bearing either wild-type or 
mutant trt1, strains were restreaked three times, and telomere length was measured by 
Southern blot. While mutations of glutamic acid 101 (E101) to lysine and asparagine 124 
(N124) to alanine had no consistent effect on telomere length (Figure 19B), multiple 
independent transformants expressing the trt1E98K allele (glutamic acid 98 to lysine) 
displayed longer than normal telomeres (Figure 19B).
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Figure 19. A mutation in the N-terminal domain of S. pombe Trt1 causes telomere 
lengthening and alters telomere sequences. 
A. Alignment of a portion of the TEN domain is shown for S. cerevisiae Est2p and S. 
pombe Trt1p (based on 161). Positions showing amino acid similarity are 
highlighted in gray. Three residues of S. pombe Trt1p that align with S. cerevisiae 
residues E76 and N95 are indicated (*; Est2p E76 can be arbitrarily aligned with 
E98 or E101 of Trt1p).  Secondary folds predicted by the crystal structure of 
Tetrahymena thermophila TERT are indicated. 
      B. Mutations at each of the three residues indicated in Figure 19A (E98K, lanes 2,      
           3,10, 11,12, 13; E101K, lanes 4 and 5; and N124A, lanes 6 and 7) were created on  
a plasmid bearing the kanMX4 marker and introduced into a trt1-::his3+ strain 
bearing a trt1+     complementing plasmid with an HSV1-tk marker gene (CF797; 
Table 4).  A plasmid expressing wild-type trt1+ was transformed as a control 
(lanes 1, 8, and 9).  Transformants were selected on  plates containing geneticin 
and subsequently streaked on plates containing 5-fluoro-2’ deoxyuridine (5FUdR) 
to select for loss of the complementing plasmid (see Chapter IV).  A single 
transformant was restreaked twice on plates containing geneticin, DNA was 
isolated from two colonies (For E98K, 6 colonies are picked), and telomeres were 
examined by Southern blot after cleavage with EcoRI. The sizes of radiolabeled 
molecular weight markers are indicated (M). 
C. Mutation of trt1 residue G98 to lysine alters telomere sequences in vivo. Telomeres in   
     a trt1- strain were allowed to shorten before reintroduction of trt1+ or trt1E98K on a    
plasmid.  Newly synthesized telomere sequences were obtained as described in 
Chapter IV.  S. pombe telomeres consist of a 5’-GGTTAC core sequence followed by 
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a variable spacer.  The occurrence of abnormal core sequences (_GTTAC or 
GG_TAC) was determined. “Percent of abnormal telomeres” is calculated as the 
percent of total sequenced telomeres that contain at least one abnormal core sequence.  
The differences are statistically significant by Fisher’s exact test (p<0.002 for the 
percent of abnormal telomeres and p<0.03 for the percent of abnormal telomeric 
repeats).  
 
 
 
 
 
 
 86 
            To assess whether telomere lengthening might occur through a similar mechanism 
to that observed in S. cerevisiae, we sequenced telomeres of the trt1+ and trt1E98K strains.  
S. pombe telomere repeats contain a 5’-GGTTAC core sequence followed in most cases 
by either no spacer, a single A residue, or an A with a variable number of Gs.  By 
multiple criteria (overall length, sequence distribution, and number of consecutive G 
residues), the spacer sequences are unaffected by the mutation. In contrast, a significantly 
higher fraction of the core sequences are abnormal [_GTTAC or GG_TAC (Figure 19C, 
p<0.03)] in the trt1E98K mutant.  Most strikingly, nearly every trt1E98K telomere has at 
least one abnormal repeat (86%) compared with only 23% of WT telomeres (p<0.002).  
The occurrence of abnormal _GTTAC  core sequences is probably underestimated 
because it is impossible to distinguish whether a preceding G residue derives from spacer 
or core sequences.  These data demonstrate that residue E98 of trt1+ influences how S. 
pombe telomeric repeats are generated, maybe through a similar mechanism as residue 
E76 in S. cerevisiae. 
 
Discussion 
We provide evidence that telomerase negatively influences telomere length through three 
distinct mechanisms corresponding to the three classes of est2 mutations that over-
elongate telomeres. Unexpectedly, a subset of these mutants decreases the frequency of 
Rap1p association with telomeric chromatin in vivo. While over-elongation is 
accompanied by changes in telomere sequence, such alterations are not restricted to 
strains in which Rap1p binding is reduced and do not decrease the binding of Rap1p to 
telomeric DNA in vitro. These data provide evidence that the catalytic subunit of 
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telomerase directly or indirectly influences the association of Rap1p with telomeric DNA 
in a manner independent of telomere sequence, suggesting that telomerase plays roles 
upstream and downstream of Rap1p in the regulation of telomere length. 
 
Mechanisms of telomere over-elongation by est2 alleles 
Previous studies identified telomere over-elongating mutations in three regions of EST2. 
The “up” mutations in the finger subdomain alter interaction of Est2p with Pif1p 90, a 
helicase that disrupts the association of telomerase with its DNA substrate 89. In contrast 
to the est2-up mutations, both est2-LT alleles tested here cause additional telomere 
lengthening in the absence of PIF1, indicating that these mutant proteins preserve normal 
interaction with Pif1p. Differential effects of est2-up34 and the est2-LT mutations on 
Rap1p association with telomeric DNA in vivo underscore this distinction. 
 The mechanism of telomere over-elongation by the est2-motifE allele is more 
complex. This mutation mimics the viral consensus sequence within motif E of the RT 
domain and increases nucleotide-addition processivity in vitro 148, a phenotype not shared 
by est2-LTE76K or est2-LTN95A 160. Despite this difference, est2-motifE decreases Rap1p 
association with telomeres in vivo in a manner indistinguishable from est2-LTE76K. 
Persistence of the est2-motifE long-telomere phenotype in the absence of Rap1p 
association, however, suggests that altered enzymatic activity may contribute to telomere 
over-elongation. 
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Generation of abnormal sequences in long-telomere strains 
Properties of yeast telomerase that influence telomere sequence in vivo are poorly 
understood. A previous study revealed normal sequences in strains with short but stable 
telomeres (tel1Δ and ku70Δ; ref. 153). For the first time, we report a consistent change in 
telomere sequence in est2 strains with long telomeres. The ubiquity of this effect suggests 
that telomerase activity may be altered under conditions of over-elongation. 
Alternatively, each est2 mutation may similarly affect telomerase catalysis in vivo, 
despite increasing telomere length through genetically distinct pathways. The est2-LTE76K 
mutation increases repeat-addition processivity of telomerase on certain primers in vitro 
37. However, our observation that the number of nucleotides added per telomere-
lengthening event is not increased in this mutant (average 82 nt in WT versus 58 nt in 
est2-LTE76K, p=0.084; Figure 15) suggests that this effect does not contribute to telomere 
over-elongation in vivo. 
The most obvious explanation for increased GG-dinucleotide incorporation is an 
increased propensity of telomerase to reach the end of the template before dissociating or 
translocating. We addressed this possibility using an RNA template mutant containing a 
U at position 469 (Figure 16A; ref. 14). WT and est2-LTE76K strains incorporate the 
complementary A at indistinguishable rates (10.6% and 9.9% of total repeats, 
respectively). Therefore, any change in nucleotide addition processivity is restricted to 
template residue C470. This interpretation assumes that excess GG dinucleotides are 
templated by residues 471CC470, as previously demonstrated for WT 14. Indeed, a mutation 
that eliminates the templating CC dinucleotide (472CAC471 to ACA) abolishes GG 
dinucleotides in est2-LTE76K telomeres (data not shown). Combined, these observations  
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Figure 20. Model that explains how reduced Rap1p binding with telomeres causes 
telomere lengthening.  
      Telomere length is regulated by Rap1p’s counting via its interaction with Rif1p and 
Rif2p. Tel1p is the downstream target of this counting pathway. Altered telomeric 
sequences by est2-LT mutants result in reduced Rap1p binding per telomere length unit 
(Figure 13), which in turn forces the lengthening of telomeres in order for certain amount 
of Rap1p to bind and reach an equilibrium of telomere length. The dependence of Rap1p 
and Tel1p support this model (Figure14; ref. 160). For rif2Δ and est2-up34, Rap1p 
association with telomeres per unit remains the same as wildtype and total amount of 
Rap1p associated with telomeres is increased (Figure 13).  
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are inconsistent with large changes in nucleotide-addition processivity. We propose that 
the spectrum of permitted primer/template alignments is altered under conditions in 
which the normal negative regulation of telomere length is compromised. 
 
Association of Rap1p with telomeres in vivo 
We were surprised to discover that est2-LT and est2-motifE strains do not increase Rap1p 
association with telomeres in vivo, despite increasing telomere length by ~30%. Failure to 
detect this increase is not an experimental limitation, since est2-up34 and rif2Δ strains 
similarly over-lengthen telomeres, but significantly increase the immunoprecipitation of 
telomeric DNA with Rap1p. We hypothesize that telomere over-elongation in an est2- 
LTE76K strain is a response to reduced Rap1p association, since lengthening is not 
observed when Rap1p’s regulatory function is bypassed in the “humanized” strain 
(Figure 20). We cannot exclude the possibility that increased processivity of Est2-LTE76Kp 
contributes to telomere over-elongation (and is suppressed by the humanized TLC1 
template). However, a model in which reduced Rap1p association causes telomere 
lengthening is consistent with our previous observation that expression of the est2-LTE76K 
phenotype requires Tel1p, a downstream effector of the Rap1p pathway 160. Furthermore, 
this model also explains the lack of significant change in the frequency or extent of 
telomere addition by est2-LTE76K telomerase in a single cell cycle (Figure 15), since the 
telomeric substrates undergoing elongation have not previously encountered the mutant 
enzyme and are expected to bind Rap1p normally.  
 What accounts for the reduced association of Rap1p with est2-LT and est2-motifE 
telomeres in vivo? Our original hypothesis that Rap1p binding is reduced by changes in 
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telomere sequence is inconsistent with the observation that est2-up34 telomerase 
generates similarly altered telomere sequences, but increases overall Rap1p association in 
vivo. Furthermore, sequences generated by est2-LTE76K telomerase bind recombinant 
Rap1p at least as well as WT in vitro. Conflict between our observations can be 
reconciled if a mechanism independent of DNA sequence influences Rap1p association 
with telomeres in vivo. One possibility is that telomerase, either directly or indirectly, 
promotes the loading of Rap1p onto newly synthesized terminal sequences. Upon the 
reduction of this activity in est2-LT strains, telomeres continue to elongate until Rap1p 
binds at a level equivalent to that found at normal length telomeres. In this light, it is 
interesting to note that several subunits of the INO80 chromatin-remodeling complex 
have been recently shown to negatively regulate telomere length, perhaps through 
physical interaction with the telomerase complex 167. Therefore, telomerase may 
participate in the normal formation of telomeric chromatin. Identification of other long-
telomere strains that fail to increase Rap1p association will address these intriguing 
possibilities. 
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CHAPTER IV 
 
 
MATERIALS AND METHODS 
 
 
Saccharomyces cerevisiae strains and plasmids 
Strains utilized are summarized in Table 4.  The est2-LTE76K mutation and an overlapping 
HindIII restriction site were generated by PCR utilizing primers HindIIIR 
(5’GTACGTTGTTGTAAAGCTTGCCCGTCAACAGG) and HindIIIF 
(5’CCTGTTGACGGGCAAGCTTTACAACAACGTAC).  Residues introducing the 
E76K mutation are bold and the HindIII restriction site is underlined.  pKF409-TVL268 
[ProA-EST2 URA3; ref. 50] was template.  The mutagenized PCR product was cleaved 
with AflII and NheI and ligated to the corresponding sites of pKF409-TVL268.  pKF408-
E76K was created by cloning the AflII-NheI fragment of pKF409-E76K into pKF408 
[untagged EST2 URA3; ref. 134].  The entire cloned fragment was sequenced. 
 PKF408-N95A AatII was created as described above using mutagenic primers 
5'CTGAAATGAAGACGTCGCAAATAGTCTTTTTTGC and 
5'GCAAAAAAGACTATTTGCGACGTCTTCATTTCTAGC (nucleotides introducing 
the N95A mutation are bold; the AatII restriction site is underlined).  The resulting PCR 
product was cleaved with PflMI and AflII and ligated into the corresponding sites of 
pKF408 (EST2 URA3).  The cloned fragment was fully sequenced.  
 A strain containing the est2-LTE76K allele integrated at the endogenous locus was 
created by cleaving pKF408-E76K with ClaI and transforming strain YKF201 (see Table 
1) by two-step gene replacement 168 to create strain YKF201-E76K.  
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Table 4.  Strains used in this thesis. 
Strain Genotype Source 
TVL268 MATa ura3-52 ade2-101 lys2-801 leu2- Δ1 trp1- Δ1 his3- Δ2 CF+TRP1 SUP11 V. Lundblad 
YKF120-404 TVL268 est2Δ::HIS3/ pKF404 (EST2 URA3 CEN) This thesis 
YKF120-410 TVL268 est2Δ::HIS3/ pKF410 (ProA-EST2 URA3 CEN) This thesis 
YKF120-410LT TVL268 est2Δ::HIS3/ pKF410-est2-LT (ProA-est2-LT URA3 CEN)a This thesis 
YKF114-404 TVL268 est2Δ::HIS3 rad52::LEU2/pKF404 This thesis 
YKF114-410 TVL268 est2Δ::HIS3 rad52::LEU2 /pKF410 This thesis 
YKF114-E76K TVL268 est2Δ::HIS3 rad52::LEU2 /pKF410-E76K (ProA-est2-LTE76K URA3 CEN) This thesis 
YKF201b MATa trp1 leu2 ura3 his7 95 
YKF201-a MATa trp1 leu2 ura3 his7 This thesis 
YKF201-E76K YKF201 est2-LTE76K This thesis 
YKF202 YKF201 tel1Δ::KANR This thesis 
YKF202-E76K YKF202 est2-LTE76K This thesis 
YKF203 YKF201 yku70Δ::KANR This thesis 
YKF203-E76K YKF203 est2-LTE76K This thesis 
YKF204 YKF201 rif1Δ::KANR This thesis 
YKF204-E76K YKF204 est2-LTE76K This thesis 
YKF205 YKF201 rif2Δ::KANR This thesis 
YKF205-E76K YKF204 est2-LTE76K This thesis 
DKF206 MATa/MATa trp1/trp1 leu2/leu2 ura3/ura3 his7/his7 This thesis 
DKF207 MATa/MATa trp1/trp1 leu2/leu2 ura3/ura3 his7/his7 est2-LTE76K/est2-LTE76K This thesis 
DKF208 MATa/MATa trp1/trp1 leu2/leu2 ura3/ura3 his7/his7 EST2/est2-LTE76K This thesis 
BY4705a MATa ade2::hisG his3D200 leu2D0 lys2D0 met15D0 trp1D63 ura3D0 hdf1::LEU2 R. Wellinger 
GA426 MATa ade2::hisG ura3-52 his3-11 leu2 trp1 can1::hisG VR::ADE2-TEL 14 
YKF500 GA426 est2-LTE76K This thesis 
YKF501 GA426 est2Δ::TRP1 This thesis 
YKF502 GA426 rif2Δ::TRP1 This thesis 
YKF503 YKF501 pif1Δ::KanR This thesis 
YKF504 YKF501 tlc1-human pKF417 This thesis 
YKF505 GA426 rad52Δ::LEU2 This thesis 
YKF506 YKF500 rad52Δ::LEU2 This thesis 
YKF507 YKF505 tlc1 Δ::KanR This thesis 
YKF508 YKF506 tlc1 Δ::KanR This thesis 
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a pKF410-est2-LT are variants of plasmid pKF410 expressing mutant est2-LT alleles (est2-LTG75A, est2-LTE76K, 
est2-LTN95A, est2-LTN95D, est2-motifE) as indicated in the text. 
b   This strain was previously named 4053-5-2. 
YKF209 MATα trp1 leu2 ura3 his7 rif2Δ::TRP1 This thesis 
YKF210 YKF201 pif1Δ::KanR This thesis 
FYBL1-23D MATα ura3Δ851 his3Δ200 trp1Δ63 86 
YKF510 FYBL1-23D est2-LTE76K This thesis 
UCC5706 MATa-inc ura3-52 lys2-801 ade2-101 ochre trp1-63 his3-200 leu2-1::GAL1-HO-
LEU2 TELVIIL::ADE2-TG1-3-Hosite-LYS2 rad52::HISG 
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YKF610 UCC5706 est2-LTE76K This thesis 
CF797 h-, leu1-32 ade6-M210 ura4-D18 his3-D1 trt1-::his3+  
[pNR210-trt1+ (HSV1-tk, ade6+, trt1+)] 
P. Bauman 
 
Table 4, continued 
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Complete gene disruptions of TEL1, YKU70, RIF1, and RIF2 were obtained by 
amplifying the KANR gene and flanking DNA from the appropriate strain [Open 
Biosystems, Huntsville, AL; ref. 169].  After transformation of the PCR product into 
YKF201and YKF201-E76K, transformants were selected on YPD media containing 
200µg/mL geneticin.  Successful knockout was confirmed by PCR and/or Southern blot. 
 Homozygous diploid strains were obtained by transforming YKF201 and 
YKF201-E76K with pHO, a plasmid expressing the HO endonuclease 170.  Transformants 
were restreaked twice, plated on 5-FOA to select for plasmid loss, and tested for diploidy.  
The heterozygous diploid strain (EST2/est2-LTE76K) was obtained by mating YKF201-
E76K with YKF201α (obtained by sporulation of the EST2/EST2diploid described 
above). 
est2-LTE76K was integrated into GA426, FYBL1-23D and UCC5706 by two-step 
gene replacement to create YKF500 and YKF510 and YKF610, respectively. EST2 was 
replaced with TRP1 in GA426 by transforming a SacI-SphI fragment from pKF404-
HXTRPa (TRP1 from pRS314 cloned into the HindIII and XbaI sites of pKF404; 50 to 
create YKF501. RIF1 was replaced with KanR in GA426 to create strain YKF502 160. 
RIF2 was replaced in YKF201-α and GA426 by TRP1 using pFA6a-TRP1 171 as template 
to create strains YKF209 and YKF503, respectively. A heterozygous diploid (EST2/est2-
LTE76K RIF1/rif1Δ RIF2/rif2Δ) was generated by mating YKF204-E76K (YKF201 est2-
LTE76K rif1Δ::KanR) and YKF209. 
             The RAD52 gene in GA426 and YKF500 was replaced with LEU2 by 
transforming a BamHI fragment from plasmid pSM20134 to create strain YKF505 and 
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YKF506. TLC1 gene in these strains was disrupted with KanR using PCR product 
generated by primes: 5’-ACCTTCTTTGTAGCTTTTAGTGTGAA 
TTTTCTGGTTTGAGCGGATCCCCGGGTTAATTAA-3’ and 5’-TATATTCTAAAA 
AGAAGAAGCCATTTGGTGGGCTTTATTAGAATTCGAGCTCGTTTAAAC-3’ to 
create strains YKF507 and YKF508. 
 PIF1 gene disruption was accomplished in YFK201 by transforming a PCR 
fragment [primers: 5’-GTAGTTTTGTGATGCTGTTCAG-3’ and 5’-GTGAGTTA 
GTCTCCTTTGGC-3’; template: genomic DNA from pif1Δ::KanR strain (Open 
Biosystems, Huntsville, AL)] to generate YKF210. TLC1 was replaced with tlc1-human 
as described 155 in strain YKF501 [containing pKF417 (EST2 CEN LEU2)] to create 
YKF504. Following transformation with pKF410 (ProA-EST2 CEN URA3; ref. 160 or its 
mutant derivatives, colonies were screened for loss of pKF417. 
 
Schizosaccharomyces pombe strains and plasmids 
Genotype of the S. pombe strain utilized in this study (CF797) is listed in Table 4.  
Plasmid pKAN-trt1+ 172 contains the wild type trt1+ gene and a KanMX4 selectable 
marker.  To facilitate mutagenesis, a KpnI-SalI fragment containing the majority of the 
trt1+ open reading frame was subcloned into pUC19 to create pUC19-trt1+.  Standard 
PCR-mediated site-directed mutagenesis was used to separately introduce mutations of 
glutamic acid 98 to lysine, glutamic acid 101 to lysine, and asparagine 124 to alanine by 
amplification of a portion of trt1+ between unique XbaI and BglII restriction sites.  The 
mutant PCR products were cleaved with XbaI and BglII and ligated to pUC19-trt1+ 
vector cleaved with the same restriction enzymes.  To facilitate cloning of the 
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mutagenized SalI-KpnI fragment back into pKAN-trt1+, a KpnI site within the polylinker 
of pKAN-trt1+ was destroyed by partial digestion with KpnI, treatment with T4 DNA 
polymerase, and religation to create pKAN-trt1+ -Kpn.  A completely sequenced SalI-
KpnI fragment of each pUC19-trt1 mutant was transferred back into pKAN-trt1+–Kpn by 
ligation between a unique SalI site and the remaining KpnI site.  Each of the resulting 
plasmids bearing mutant or wild-type trt1 were transformed into a trt1-::his3+ strain 
bearing a trt1+ complementing plasmid with an HSV1-tk marker gene (CF797; Table 4).  
Transformants were selected on YES (yeast extract supplements) plates containing 100 
µg/ml geneticin and subsequently streaked on YES plates containing 5-fluoro-2’ 
deoxyuridine (5FUdR; 50µM) to select for loss of the complementing plasmid.  After two 
restreaks on plates containing geneticin, DNA was isolated by glass bead lysis, cleaved 
with EcoRI, Southern blotted, and probed with a telomeric fragment. 
 
Screen for long-telomere mutants 
Construction of pKF410-est2-LTN95A, est2-LTG75A, and est2-LTN95D has been described 50.  
Additional alleles of est2-LT were created by a gap repair approach utilizing unique AflII 
and PflMI restriction sites located at amino acids 59 and 119 of Est2p, respectively.  
Primers JW75 (5’-GTTTCGCACTACCAAATTCAAG) and JW95 (5’-
CTGCCCATTAAATTGAATTACTG) were used to amplify a 305 base pair fragment by 
error prone PCR as described 173.  The resulting PCR product and pKF410 FS vector 
(linearized with AflII and PflMI) were cotransformed into strain YKF120 (Table 1; 
following loss of complementing plasmid on 5-FOA).  pKF410 FS was created by 
ligating an NheI-AflII fragment of pKF408-N95A AatII (see above) into the NheI-AflII 
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sites of pKF410.  The resulting plasmid was cleaved with AatII, treated with T4 DNA 
polymerase, and religated.  
Ura+ transformants obtained by gap repair were restreaked several times to 
eliminate mutants that inactivated EST2.  DNA was isolated from transformants showing 
robust growth after the third restreak using either the DNA-Pure Yeast Genomic kit (CPG 
Inc.) or bead lysis 174 and telomere length was analyzed by Southern blot as previously 
described 50 following cleavage with PstI or XhoI as indicated in the figure legends.  
Genomic DNA from strains showing longer-than-normal telomeres by Southern blot was 
used to transform E. coli by electroporation and rescued plasmids were retested for 
effects on telomere length. 
 
In-gel hybridization procedure 
In-gel hybridization was done as described with some modifications [175, A. Bertuch, 
personal communication].  A 22mer (5’CCCACCACACACACCCACACCC) was gel 
purified and labeled by incubation at 37°C for 45 min with γ32P-ATP and T4 
polynucleotide kinase (Roche).  Yeast genomic DNA was isolated using bead lysis 174 
and equivalent amounts of DNA were digested by XhoI in a 100 µl reaction volume.  
Reactions were terminated by precipitation with 20µL 3M NaOAc and 660µL 100% 
EtOH.  Pellets were resuspended in 12µL binding buffer (10 mM Tris-HCl, 50 mM NaCl, 
10 mM MgCl2, 1 mM dithiothreitol, pH 7.9 at 25°C) and 1µL probe (100,000cpm) was 
added to each sample and incubated for 10min at 37°C, followed by incubation for one 
hour on ice.  Samples were loaded on Sephadex G50 columns to eliminate unbound 
probe.  DNA samples were separated in a 0.7% agarose gel by electrophoresis for 16hr at 
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~2V/cm in the cold room. Gels were dried at 23˚C (using a SGD5040 Slab Gel Dryer; 
Savant) for 24-28min until the gel was very thin and even, and the gel was exposed to 
Phosphorimager screen. 
To denature the chromosomal DNA, the gel was washed in denaturing solution 
(0.15M NaCl, 0.5M NaOH) for 25min at RT, followed by a 25-min wash in neutralizing 
solution (0.15M NaCl, 0.5M Tris HCl, pH 8.0). The gel was briefly prehybridized with 
25ml hybridization solution 78 and 18µl of the probe described above was added.  The gel 
was incubated at 36°C overnight.  The gel was washed in 0.25xSSC at RT overnight and 
exposed to phosphorimager screen. 
 
Primer competition assay 
 
Extract preparation and immunoprecipitation of Protein A tagged Est2p was performed as 
described134 except that beads were washed two times with TMG (10 mM Tris-Cl at pH 
8, 1 mM MgCl2, 10% glycerol, 0.1 mM DTT) plus 200 mM NaCl and 0.5% Tween-20, 
twice with TMG [plus 2µl/ml RNasin (Promega)], and resuspended in 20 µl of TMG 
(plus 2 µl/ml RNasin, 0.5 mM DTT).  Prior to immunoprecipitation, extract 
concentrations were adjusted to 20 mg/ml.  Packed beads (5 µl) from the 
immunoprecipitation were mixed with 0.5 µl of water or 0.5 µl of 1 mg/ml RNase A and 
incubated 10 min. at 30˚C.  5.5 µl of a 2X reaction mixture consisting of 80 mM Tris-Cl 
at pH 8, 100 mM NaCl, 10% glycerol, 5 mM MgCl2, 1 mM spermidine, 1 mM DTT, 5 
µM initial substrate oligonucleotide (see below), 200 µM each dTTP, dATP, and dCTP, 
and 1.5 µl [α32P]dGTP (800 Ci/mM; 10 µCi/µl) was added per sample on ice and the 
reaction was initiated by incubation at 30˚C.  After 7 minutes, 1.4 µl of 20 µM challenge 
oligonucleotide (or 1.5 µl buffer) was added and the incubation was continued for an 
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additional 23 minutes.  The reaction was stopped by addition of 1.5 µl of stop buffer (250 
mM Tris at pH 8, 250 mM EDTA at pH 8, 2% SDS) and 1.75 µl of proteinase K (20 
mg/ml) for 30 minutes at 60˚C.  Reaction products were phenol extracted, precipitated, 
and separated in a 12% acrylamide/8M urea sequencing gel.  Product was quantitated 
after exposure to phosphorimager.  Oligonucleotide +1 marker was made by treating the 
appropriate oligonucleotide with terminal transferase (GE Healthcare) in the presence of 
[33P]ddTTP.  Substrate (and challenge) oligonucleotides were as described 36:  14 (5’ 
GTGTGGTGTGTGGG); 5’NT (5’ GACCGCGGTGTGTGGG); and 29 (5’ 
GGGTGTGGTGTGTGGGTGTGGTGTGTGGG). 
 
Nucleotide-addition processivity 
Extract preparation and immunoprecipitation were as described above.  To visualize 
differences in processivity between wild-type and est2-motifE strains, the conditions of 
the telomerase assay were modified as described 148.  Reactions were incubated at room 
temperature for 1 hour, then processed as described above.  Reaction products were 
quantified by determining the intensity of each band (+1 to +7) by phosphorimager 
analysis.  Processivity+3 was calculated as the sum of signal in bands +4 to +7 divided by 
the total amount of signal in bands +1 to +7.  Signal was corrected for specific activity by 
dividing the intensity of each position by the number of G residues expected to be 
incorporated into product at that position (+2, +3 = 1; +4 = 2; +5, +6 = 3; +7 = 4). 
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Analysis of primer binding 
Extract preparation, immunoprecipitation, and telomerase assay were done essentially as 
described above for the primer competition assay with the following adjustments.  All 
dNTPs were omitted and [α32P] dTTP (800 Ci/mM; 10 µCi/µl) was substituted for dGTP.  
Primer was added to immunopurified telomerase at 5X decreasing final concentrations of 
2.5 µM, 0.50 µM, 0.10 µM, 0.02 µM, 0.004 µM, and 0.0008 µM for 10 minutes on ice.  
Reactions were initiated by the addition of telomerase reaction mix containing dTTP and 
allowed to proceed for seven minutes at 30˚C before being terminated by the addition of 
STOP buffer and proteinase K as described above.  Equal amount of an end-labeled 29-
mer oligonucleotide was added to each sample prior to phenol extraction and 
precipitation to serve as a loading control.  Reaction products were quantified by 
phosphorimager.  The intensity of each +1 product band (corrected for background) was 
divided by the intensity of the loading control to correct for variations in yield during 
sample processing.  The corrected value for the +1 product was then normalized to that of 
the highest primer concentration to correct for variations between experiments in specific 
activity of the loading control. 
 
Western blotting 
Protein extraction and immunoprecipitation with IgG Sepharose beads (GE Healthcare) 
were performed as previously described 134.  Samples were loaded on a NuPAGETM 10% 
Bis-Tris Gel (Invitrogen). Protein was transferred to Hybond-P membrane (GE 
Healthcare). Primary antibody was mouse monoclonal anti-Protein A (Sigma). Secondary 
was peroxidase-conjugated goat anti-mouse antibody (Chemicon International). 
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Cloning and sequencing of S. cerevisiae telomeres 
Multi-cell cycle analysis. YKF501 bearing plasmid pKF410 was restreaked on plates 
containing 5-fluoroorotic acid (5-FOA) and restreaked once to allow telomere shortening. 
After reintroduction of pKF410 bearing WT or mutant est2-LT, transformants were 
restreaked three times (~75 generations). Genomic DNA was extracted by glass bead 
lysis 174 and telomere PCR was performed 86. After gel purification (Qiagen), products 
were ligated into pGEM T-easy (Promega) according to manufacturer’s instructions. 
Inserts were sequenced by FASTERIS (Plan les Quates, Switzerland) using primer 
M13F.  
Isolation of telomeres extended in a single cell cycle. A fresh GA426 est2Δ::TRP1 
colony (“recipient”) was grown overnight in 5 ml SD-Trp medium. 1X108 telomerase-
deficient recipient cells were mixed with 1X109 cells of strains FYBL1-23D or YKF510 
(donor) as described 86 and incubated at 30°C for 4 hours on YPD plates. Mating 
efficiency [monitored by comparing growth on SD-Trp (recipients and diploids) with 
growth on SD-Leu-Trp (diploids only)] was nearly 100% (data not shown). Telomere 
PCR was performed as above. 
Isolation of telomeres added to a newly-formed telomeric end. UCC5706 and 
UCC5706-E76K strains were pregrown in SD-Lys (2% glucose) overnight, diluted into 
YEP-2.5% raffinose for three or four generations before being arrested with 10mg/ml 
nocodazole (in DMSO, final concentration of 10ug/ml) for 4 hours. Cells were 
centrifuged and resuspended in YEP-3% galactose and grown overnight. Genomic DNA 
was extracted and telomere PCR was performed as above, with primers 5’- 
GCCAAGATATCAAAC 
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TGTAAAT-3’ and 5’-CGGGATCCG18-3’. 
 
Cloning and Sequencing of Schizosaccharomyces pombe telomeres 
CF797 was streaked on YES plates containing 5-fluoro-2’ deoxyuridine (5FUdR; 50µM) 
to select for loss of the complementing plasmid. Plasmids pKAN-trt1+-Kpn and pKAN-
trt1E98K-Kpn were transformed and selected on YES (yeast extract supplements) plates 
containing 100 µg/ml geneticin. After two restreaks on plates containing geneticin, DNA 
was isolated by glass bead lysis, and telomeric sequences were amplified as previously 
described and sequenced as described above.  
 
Chromatin immunoprecipitation and dot blot 
ChIP was performed as described, with some modifications 176. Yeast strains were grown 
to OD600= ~0.5 (50ml in YPD). Crosslinking was initiated with 1.4mL 37% formaldehyde 
and terminated after 5 minutes by addition of 2.5mL 2.5M glycine. Cells were pelleted 
and washed sequentially with HBS (50mM HEPES pH 7.5, 140mM NaCl) and ChIP lysis 
buffer with PMSF (50mM HEPES pH 7.5, 140mM NaCl, 1mM EDTA pH 8.0, 1% 
IGEPAL CA-630, 1% sodium deoxycholate and 1mM PMSF). Pellets were resuspended 
in 400µl ChIP lysis buffer (plus one Roche Complete Mini-Protease Inhibitor tablet per 
10ml) and disrupted by glass bead lysis. Lysate was obtained by centrifugation and DNA 
was sonicated to fragments of 500-1000bp. Sonicated lysate was cleared twice by 
centrifugation at 7000K for 2 minutes and input samples (25µl of 400µl) were obtained. 
Remaining lysate was incubated on ice with 20µl anti-Rap1p antibody (Santa Cruz 
Biotechnology). Samples were immunoprecipitated with 80µl Protein G Dynabeads 
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(Invitrogen). Crosslinking was reversed by overnight incubation at 65°C and DNA was 
detected by dot blot. Probe was random-primed S. cerevisiae telomeric DNA or a random 
primed fragment from the ARO1 gene (primers 5′-TGACTGGTACTACCGTAACGGTT 
C-3′ and 5′-GAATACCATCTGGTAATTCTGTAGTTTTGAC-3′). Data analysis has 
been described 177. 
 
Analysis of telomere sequence data 
Data analysis utilized newly synthesized sequences identified by alignment of identical 
internal repeats. The frequency of GG-dinucleotide incorporation was calculated as the 
number of 5’-TGGGTGT sequences followed by GG divided by total 5’-TGGGTGT 
sequences. When a core sequence overlapped with an adjacent repeat (5’-
TGGGTGTGGGTGT), the 5’ core (underlined) was considered to lack the GG. Such 
overlapping core sequences generate a spacer with a value of -1. The frequency of 
“overlapping core sequences” is defined as the number of spacers in the -1 class divided 
by total spacers. Predicted Rap1p binding sites were identified as described 153 with 
MatInspector (www.genomatix.de) using a 14 bp similarity matrix to assign confidence 
scores 178. 
 
Rap1 protein expression, purification, and binding assays 
Protein expression from pET28a (+)-Rap1p (XhoI-EcoRI) 179 was induced overnight in 
BL21 E. coli with 1 mM IPTG (isopropyl-β-D-thiogalactopyranoside) at 16˚C. 
Recombinant His6-tagged full-length Rap1p was purified on NTA-agarose beads 
(Qiagen) by manufacturer’s instructions and purified by ion-exchange chromatography. 
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Eluted protein was dialyzed in 20mM Tris-HCl (pH7.5), 50mM NaCl, 20mM KCl, 6% 
glycerol. Protein concentration was estimated by comparison with BSA standards. 
 For the gel shift assay, oligonucleotides (5’-ATATACACCCATACATTGA-3’ 
and 5’-GTCAATGTATGGGTGTATA-3’; 179 were annealed to create a single Rap1p 
binding site (bold) and labeled with Klenow polymerase (Roche) in the presence of α-
32PdCTP. 100 fmoles of 32P-labeled DNA was mixed with increasing amounts of 
unlabeled telomeric DNA (0-80 fmoles). 400 fmoles of recombinant Rap1p was added in 
20µl binding buffer [20 mM Tris-HCl (pH 7.5), 70mM KCl, 1mM dithiothreitol, 6% 
vol/vol glycerol, 25µg/ml bovine serum albumin, 2.5µg/ml poly(dG-dC), 0.1 mM EDTA] 
and reactions were incubated on ice for 10 minutes followed by 20 minutes at RT. 
Samples were separated by 6% polyacrylamide Tris/borate-EDTA gels, dried, and 
quantified by phosphorimager. 
 For DNaseI footprinting, 32P-end labeled telomeric sequences (100 fmoles) and 20 
fold excess recombinant Rap1p were mixed in 20µl binding buffer, incubated on ice for 
10 minutes, and one hour at RT. Samples were incubated with 0.5 unit DNase I 
(Promega) for 1 minute, followed by addition of 45µl stop solution (supplied by 
manufacturer). DNA was phenol/chloroform extracted and ethanol precipitated. Samples 
were resuspended in 5µl formaldehyde loading buffer, separated on 10% polyacrylamide 
gels, and analyzed by phosphorimager. 
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CHAPTER V 
 
GENERAL DISCUSSION AND FUTURE DIRECTIONS 
 
General Summary 
In this dissertation, I have explored the role of S. cerevisiae Est2p in regulating 
telomere length. As the catalytic subunit of telomerase, Est2p positively regulates 
telomere length. Interestingly, we identified several mutations clustered in the N-terminus 
of Est2p (named est2-LT) that cause telomere lengthening, suggesting that Est2p may 
contribute to negative regulation as well. These mutations do not cause detectable 
changes in catalytic nucleotide addition in vitro or alter the affinity of mutant Est2p for 
its DNA substrate. Genetic epistasis analysis suggests that the over-extension of 
telomeres in est2-LT strains is dependent upon Tel1p and acts through the Rap1p 
counting mechanism. Indeed, the association of Rap1p (per nucleotide) with endogenous 
telomeres is reduced in est2-LT strains. As a result, telomeres lengthen until enough 
Rap1p is bound to reach a new equilibrium length (Figure 20). Associated with the long-
telomere phenotype, there are certain telomere sequence changes in est2-LT strains. 
Similar changes are observed in other long telomere mutants (est2-up34 and est2-motifE), 
suggesting that sequences changes in est2-LT are a consequence, not the cause, of 
telomere over-extension. The basis of these changes is under investigation. Although the 
sequence changes modestly affect predicted Rap1p binding sites, Rap1p binds to mutant 
telomeric sequences equally well as to wild-type telomeric sequences in vitro, suggesting 
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a possible role of Est2p in regulating Rap1p binding to telomeres in vivo. Experiments to 
explore the mechanism of this effect are described below. 
Future Directions 
Why is Rap1p’s association with telomeres in est2-LT strains decreased? 
The observation that Rap1p association is reduced at est2-LT and est2-motifE 
telomeres but not est2-up34 telomeres (described in Chapter III) suggests that the effect 
on Rap1p association is less likely a general effect of over-lengthened telomeres. 
However, it is unclear how general this phenomenon might be.  We will measure Rap1p’s 
association with telomeres in other mutants that have over-lengthened telomeres (for 
example, dna2-1). If less Rap1p association only occurs in est2-LT mutants, it will 
suggests that Est2p has a direct role in influencing Rap1p association with telomeres. If 
some of the long telomere mutants in lagging strand replication machinery have reduced 
Rap1p association, this may suggest that these mutants cause telomere lengthening 
through a similar or related mechanism as est2-LT. 
Est2p might influence Rap1p’s association in two ways, indirectly and/or directly. 
Mutations in Est2p might affect chromatin assembly and consequently change Rap1p’s 
association. There is precedence for a link between replication and chromatin assembly in 
the CAF-1 complex that assembles nucleosomes on newly replicated DNA in a manner 
linked to the replication fork through PCNA180-182. It is possible that telomere replication 
must be linked to appropriate nucleosome deposition or even specifically to Rap1p 
deposition. Chromatin remodeling is mediated by two distinct classes of molecular 
processes that are highly intertwined. The first class remodels chromatin by post-
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translational modification of histones, such as acetylation, methylation, phosphorylation, 
ubiquitylation, and sumoylation. The second class is ATP-dependent and is catalyzed by 
chromatin remodeling complexes. By changing DNA-histone interactions, ATPases can 
slide, eject, insert or restructure histone octamers. One of these complexes is the INO80 
complex, several subunits of which are preferentially associated with telomeric DNA, 
consistent with a direct role of this complex at telomeres167. Deletion of INO80 subunits 
(for example, Ies3p) causes telomere lengthening. Ies3p has been shown to interact with 
Est1p, however, the significance of this interaction remains unclear. Whether any 
component of INO80 complex interacts with Est2p is unknown.  
To test whether est2-LT mutants influence Rap1p association through the INO80 
complex resulting in telomere overlengthening, double mutants between ies3Δ and est2-
LTE76K will be generated and telomere length will be assayed by Southern blotting. If 
there is no additional lengthening in the double mutant compared with est2-LTE76K, we 
can conclude that ies3Δ and est2-LTE76K act through the same genetic pathway in 
telomere regulation and that Est2p influences Rap1p association in an indirect way, likely 
through the INO80 complex. If additional telomere lengthening is observed in the double 
mutant, then Est2p may play a more direct role in dictating Rap1p association with 
telomeres, possibly via a protein-protein interaction. CoIP or yeast two-hybrid 
experiments will be performed to address this possibility.  
 Reduced Rap1p association in est2-LT and est2-motifE with telomeres might 
change the chromatin structure, although these changes might not affect the silencing of 
genes localized at telomeres (Figure 12 in Chapter III). Micrococcal nuclease and DNase 
I analysis of yeast chromatin show that the subtelomeric X and Y’ elements are 
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assembled in nucleosomes while the entire terminal tracts of TG1-3 repeats are assembled 
in a non-nucleosome structure termed the telosome183. The telosome is separated from 
adjacent nucleosome by a region of DNA that is highly accessible to enzymes and it can 
be cleaved from chromosome ends with nuclease and solubilized as protein-DNA 
complexes. Since Rap1p is a component of this telosome complex, reduced Rap1p 
association might disrupt the telosome structure and increase the sensitivity of telomeric 
chromatin to nucleases. To address this possibility, MNase and Dnase I digestion will be 
used to examine whether the telosome structure is affected in est2-LT mutants. 
 
What is the basis of the altered sequences in est2-LT strains? 
Telomerase uses TLC1 RNA as a template to add nucleotides consecutively onto 
chromosome ends, a process termed nucleotide addition processivity. After one repeat is added, 
telomerase translocates and initiates another round of nucleotide addition (repeat addition 
processivity). Yeast telomerase has low nucleotide and repeat addition processivity, which 
causes heterogeneity of the yeast telomere sequence.  This heterogeneity is proposed to arise 
from a combination of incomplete Reverse Transcription (RT) and multiple registers of 
alignment between telomeres and template RNA14. The central region of TLC1 RNA is 
incorporated in ~90% of all telomeric repeats, which is named the “core sequence” (Figure 16 in 
Chapter III). In WT cells, telomerase has only ~50% chance of copying past template residues 
471CC470 to generate a GG dinucleotide and rarely extends to the end of the template. When 
telomerase translocates, there are multiple registers in which it can align with the template, 
resulting in different numbers of TGs between “core sequences” (termed the spacer). The rate of  
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Figure 21. Proposed RNA template mutants and predicted effects on telomere 
sequence.  TLC1 RNA is shown above and chromosome sequence below.  Purple: core 
sequence. 
A. TLC1 
B. tlc1U469->A   
C. tlc1484CAC482->ACA 
D. tlc1473CAC471->ACA 
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incorporation of the GG-dinucleotide and average spacer length can be used to the behavior of 
telomerase in vivo. In est2-LT strains, there is a higher rate of GG-dinucleotide incorporation and 
significantly longer spacer regions. Although the increased incorporation of the GG dinucleotide 
is most easily explained as an increase in nucleotide addition porcessivity, the lack of increased 
incorporation of position 469 suggests that increased Type I processivity cannot explain the 
alterations in telomeric sequences (Figure 21B; Chapter III).  
The presence of extremely long spacers (>10nt) in WT strains suggests that the spacer 
can be generated by the slippage of telomerase. So the increased spacer length can’t be fully 
accounted for by increased processsivity. At least some heterogeneity in TG repeats must arise 
from multiple alignment registers in the 3’ end of the template. Expression of tlc1 484ACA482 to 
CAC increases the number of base pairs formed between a GG dinucleotide-containing 3’ 
terminus and the RNA template (Figure 21C). In WT cells, this increased pairing “locks” the 
alignment register such that all GG sequences are followed by a single TG dinucleotide. If, in 
this mutant, spacers are reduced to 1 TG, it will suggest that the longer spacers in est2-LTE76K 
arise in part from preferential alignment of the mutant enzyme at the extreme 3’ end of the RNA 
template. Southern Blotting will be used to determine whether telomere lengthening is 
suppressed. If the long spacers still exist, it will imply that this mutant enzyme is extremely 
prone to slippage or abortive RT.  
In the process of analyzing telomeric sequences resulting from different RNA template 
mutant in wild-type or E76K background, I made several interesting observations. First, in 
presence of the U469->A mutant (Figure 21B), the frequency of GG incorporation and 
overlapping core sequences are greatly changed (Table 5). Secondly, in the tlc1473CAC471 to  
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Table 5. Sequence changes in tlc1U469 to A template mutant. 
 
GG incorporation (Percent)  
WT E76K 
WT template 52.5 67.10 
U469 to A 68.2 32.6 
 
Overlapping core sequences (Percent)  
WT E76K 
WT template 29.2 17.5 
U469 to A 36.8 63.3 
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ACA mutant where GG incorporation is disrupted (Figure 21D), in presence of WT telomerase 
there is always a spacer between two core sequences (TGGGTTG). In contrast, in presence of 
E76K telomerase there are 25% neighboring core sequences (TGGGTTGTGGGTTG, 
significantly different from WT, p=0.0015) that are most likely generated the same way as the 
overlapping core sequences. Although these changes are striking and interesting, we are unable 
to come up with a model of telomerase synthesis that could explain these data. More RNA 
template mutants will be utilized to distinguish the behavior of WT and mutant telomerase. 
The conventional processivity assay described in Chapter II utilized a canonical DNA 
primer with maximal base-pairing with RNA template and low dGTP concentrations (~0.2µm) 
and in this assay yeast telomerase does not exhibit Type II processivity. However, recently Lue 
and colleagues modified this assay with a mutated DNA primer that has two mis-pairing with the 
RNA template and high dGTP concentration (3.2µm), and observed telomerase Type II 
processivity184. Under these conditions, Est2-LTE76K telomerase shows a weak increase in Type 
II processivity37. Although it is not consistent with the reduced average telomere addition in vivo 
(Figure 15 in Chapter III), this observation may reflect alterations in the enzymatic properties of 
Est2-LTE76K telomerase such as anchor-sites interaction. Primers with different sequences and 
length will be used in the processivity assay to test this possibility.  
WT telomerase has low type II processivity in vivo based on the observation of closely 
interspersed repeat types in strains simultaneously expressing two different template alleles36. In 
a single cell cycle experiment monitoring sequences added by either wild-type telomerase or 
est2-LTE76K telomerase were analyzed, preliminarily I found an increase in frequency of telomere 
addition although it is not statistically significant (p=0.09, Fisher’s exact test). More telomeres 
will be obtained and analyzed to get statistically significant results. I also found that the 
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frequency of telomere addition to the de novo telomeric end in rif2∆ and est2-LTE76K strains are 
both increased compared with WT strain (Figure 22A and 22B), consistent with the result from 
the single cell-cycle experiments (Figure 15; ref. 86).  This increase in frequency of telomere 
addition might result form decreased Type II processivity in vivo. A two-template single-
telomere extension assay (2T-STEX) was used to determine the Type II processivity in WT 
strain185. In this experiment, two clearly distinct RNA templates are co-expressed so that 
telomere addition by two telomerase can be easily distinguished. Telomere sequences are 
sequenced and Type II processivity can be calculated as the average number of WT or mutant 
repeats added per telomere addition event. A similar experiment will be performed co-expressing 
TLC1 and a tlc1 473CAC471 to ACA mutant in est2-LTE76K strain (Figure 21D). While this mutant 
does not significantly affect telomere length, it will incorporate a clearly distinguishable 
GGGTT(GT)n repeat. If WT and mutant RNAs are expressed at the same level (will be 
determined by RT-RCR), we would expect repeat-type heterogeneity on every replicated 
telomere. If est2-LTE76K increases Type II processivity, we would see telomeric repeats on one 
telomere are mostly WT or mutant.  
 
Are there two modes of telomerase synthesis? 
I found that telomeric sequences added by WT telomerase to a newly formed telomeric 
“seed” have a pattern that more closely resemble that of the long-telomere mutants than WT 
(Table 2 in Chapter III and Table 6). To eliminate the trivial possibility that this difference is due 
to the strain background, Robin Bairley has sequenced telomeres present at natural chromosome 
ends in this strain. She found that these natural telomere repeats are similar to those found in  
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Figure 22.  Increased kinetics of sequence addition onto the TG1–3/HO end in rif2∆ 
and est2-LTE76K strains. 
A. WT, est2-LTE76K and rif2∆ cells were arrested using nocodazole for 4 hours at 30°C.  
Galactose was added to induce HO expression. Cells were harvested at 0h, 1h, 2h, 4h, 
6h times point in nocodazole block after HO induction or grew without nocodazole 
block overnight. DNA was isolated, digested by SpeI, subject to Southern blotting 
and probed with the ADE2 probe (Grey bar). INT is an internal control fragment 
result from SpeI digestion. This assay is modified from91.  
B. Graphical representation of sequence addition onto the TG1–3/HO end. The percent of  
 addition is calculated as the reduction of the cut signal over the total cut signal. 
C. HO cleavage efficiency in strains indicated in A. It is calculated as cut signal at each  
 time point/original uncut (0h time point) signal. 
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Table 6. Sequence comparison of telomeres added to a natural chromosome end and an 
HO-cleaved end. 
 
GG incorporation (Percent)  
WT E76K 
Multiple cell cycle 52.5 67.10 
Telomeres added to XVL 53.8(70/130)  
Telomeres added to HO-cleaved end  63.5   
Overlapping core sequences (Percent)  
WT E76K 
Multiple cell cycle 29.2 17.5 
Telomeres added to XVL  28.6 (36/130)  
Telomeres added to HO-cleaved end  22.1  
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other WT strains (Table 6). Based on these results, we hypothesize that telomerase may behave 
differently during de novo synthesis than during conventional synthesis. Based on this idea, we 
would postulate that the est2-LT mutations alter the properties or regulation of telomerase so that 
mutant telomerase works in this second mode at chromosome ends. If this is true, comparing the 
behavior of telomerase at chromosome ends and DSB will unmask the mechanism of est2-LT 
affecting telomere length regulation. Although many labs use the HO cleavage assay to study the 
recruitment/regulation of telomerase, there is evidence suggesting that telomerase behaves 
differently at a DSB and at chromosome ends.  For example, the de novo end is lengthened 
efficiently in G2/M phase, while a native telomere is not elongated at all. The 
MRE11/RAD50/XRS2 genes are absolutely required for telomerase-mediated addition in the de 
novo assay, and in the absence of Rad50, the association of the single-stranded TG1-3 DNA 
binding protein Cdc13p is abolished186. In contrast, on a natural telomere, the association of 
Cdc13p with yeast telomeres occurs efficiently in the absence of Tel1p, Mre11p, Rad50p, or 
Xrs2p, and the MRX complex is not absolutely required for telomere elongation71.  
As mentioned earlier, I have found a RNA mutant (tlc1 473CAC471 to ACA) in which the 
WT and mutant telomerase behave significantly different (p=0.0015). While the basis of this 
phenomenon is unclear, this mutant can be used in the HO cleavage experiment to compare 
telomere synthesis by WT and E76K telomerase to obtain statistically significant results with a 
small set of data. 
 
Does the LT region have a conserved role in telomere length regulation? 
The crystal structure of the TEN domain in Tetrahymena TERT has been solved. Due to 
low identity (20%) between S. cerevisiae Est2p and T. thermophila TERT, preliminary model 
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building began with six different sequence alignments. Ten models were generated to each 
alignment and the top-scoring model for each alignment was visualized using Chimera software. 
Among these ten models, the model that has all the expected secondary structure in Tetrahymena 
TERT was chosen as our working model of S. cerevisiae Est2p (Figure 23A).  
In our working model, G75 and E76 are localized at α4 and N95A is localized within a 
loop between α4 and α5. These residues appear to lie on a potential functional surface that could 
interact with protein or DNA. E76 to R and E76 to A mutations are being constructed to explore 
the role of charge in generating the long telomere phenotype. Several additional residues will be 
mutated to test aspects of this model. For example, N79 located on the putative surface will be 
mutated to alanine, lysine and arginine. Since helices 4 and 6 appear important for the structural 
integrity of this region and are predicted to interact, mutations will be made at the helical 
interface (V128, L131, L73 and L77). We predict that such mutations will compromise Est2p 
structure. Indeed, a mutation of V81 (located along the interface at the end of helix 4) to alanine 
supports normal growth and telomere length, while mutation to trytophan causes telomere 
shortening and senescence (data not shown), consistent with the position of this residue in the 
interface. One interpretation of this result is that a bulky residue cannot be tolerated where the 
two helices pack tightly in the structure. Given the locations of F127 and L73 in the model, we 
are testing whether swapping the position of these two residues is compatible with protein 
function. Elliott Kim is constructing both single mutations and the double mutation. Our model 
will be further supported if the double mutation retains more function than either single mutant.  
It is attempting to speculate that polymorphisms in EST2 could contribute to differences 
in telomere length. It is interesting that the yeast Saccharomyces paradoxus (a very close relative 
of S. cerevisiae) has longer telomeres than Saccharomyces cerevisiae. QTL analysis revealed  
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Figure 23. Representative model of the TEN domain of S. cerevisiae Est2p 
A. Sequence alignment of S. cerevisiae and T. thermophila TERT used to generate 
the model shown in B. Only the portion encompassing helices 4 and 6 is shown. 
Red: identical residues. Blue: conserved. Residues mutated to produce over-
lengthened telomeres are indicated by green arrows. 
B. Model of S. cerevisiae TEN domain.  
C.  Helices 4 and 6 are magnified and amino acid side chains are shown.  
      Green indicates long-telomere mutations. Figures generated with Chimera. 
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that Est2p plays an important role in generating this telomere length (Ed Louis, personal 
communication). Sequence alignment shows that SpEst2p has an E76G polymorphism and 
Bethany Cartwright is working on determining the extent of the contribution of this residue to 
the telomere length. 
In Chapter III, I also describe a mutation in the N-terminus of S. pombe Trt1p (E98K) 
that causes telomere overelongation companied by sequence changes in vivo. Less is known 
about the RNA template in S. pombe, making it difficult to determine the basis of these sequence 
changes. Lack of more mutations that cause telomere lengthening makes it hard to conclude that 
this is a conserved region in the N-terminus of Trt1p that regulates telomere length. A PCR-
based mutagenesis method can be utilized to screen for additional mutations that result in longer 
than normal telomeres. 
Telomerase activity is up-regulated in many tumor cells, making telomerase a 
target for cancer treatment. Telomerase defects also contribute to inherited degenerative 
diseases and premature aging syndromes. Studies of a mice model lacking telomerase 
suggest that short telomere length rather than telomerase level determines the renewal 
capacity of stem cells. An understanding of telomere length regulation by telomerase and 
other regulators will be critical to create a novel method to maintain normal telomere 
length in cells with short telomeres. My study identified a novel role of Est2p N-terminal 
region in negatively regulating telomere length through Rap1p. In the process of 
understanding the underlying mechanism, I discovered several surprising phenotypes 
associated with mutations in this region that cause telomere over-elongation. These 
observations reveal interesting aspects of telomerase function and further study will 
contribute to our better understanding of telomere length regulation and drug discovery. 
 121 
APPENDIX 
 
TESTING THE INTERACTION BETWEEN Est2p AND LAGGING-STRAND 
REPLICATION COMPONENTS 
 
Introduction 
           DNA replication is one of the most important events in living cells. According to the 
current model of DNA replication, an initiator protein complex (ORC) is bound to an origin of 
replication. ORC recruits other proteins such as MCMs, Cdc6 and Cdc7/Dbf4, leading to the 
formation of an initiation complex. Following these events, DNA structure is altered locally by 
helicase activity, the single stranded DNA is protected and stabilized by Replication Protein A 
(RPA), and polymerase α/primase and helicase are recruited to initiate polymerization. After 
limited DNA synthesis by polα/primase, PCNA and RFC facilitate the switch to polδ. 
polα/primase also initiates Okazaki fragment synthesis of the lagging strand by extending an 
RNA primer, followed by replacement by polδ. Synthesis of the leading strand and lagging 
strand are likely coordinated by dimerzation of polδ holoenzymes. The RNA primer and the 
short region of DNA synthesized by polα/primase is removed by Dna2p and Fen1p and two 
adjacent Okazaki fragments are ligated by DNA ligase I. Topological constrains are released by 
Topoisomerase I.  
             This highly coordinated process encounters difficulties at the extreme end of the 
chromosome, potentially causing cumulative sequence loss. This telomere loss is counteracted 
by the activity of telomerase to add telomeric sequences de novo, followed by lagging strand 
synthesis. This order of events suggests that telomere synthesis by telomerase is likely to be 
coordinated with synthesis of the opposite C-strand.  Such coordination may prevent telomerase 
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from generating excessively long single-stranded tails, which may be deleterious to chromosome 
stability.  
             Many components of DNA replication influence telomere length. For example, in S. 
cerevisiae, Polα, Polδ and DNA primase are required for telomerase-mediated telomere addition 
to a de novo telomere91. CoIP experiments in S. pombe showed that Polα interacts with TERT, 
suggesting that these proteins physically coexist in a complex in vivo187. In a polα mutant that 
exhibited abnormal telomere lengthening and slightly reduced telomere position effect, the 
cellular level of the Trt1 (TERT in S. pombe) protein was significantly reduced and 
coimmunoprecipitation of Trt1 and Polα was severely compromised compared to wild-type Polα 
cells. These data suggest that the replication complex is in close association with Trt1p. In 
support of this model, telomerase and polymerase α-primase from Euplotes crassus are 
physically associated94. 
             Dna2p is a multifunctional protein that was first identified in budding yeast in a screen 
for temperature-sensitive mutants defective in DNA replication in a cell permeabilized assay188. 
It contains two essential domains (Figure 24), an endonuclease domain and a helicase domain. 
The endonuclease domain is essential for cell viability and is proposed to be responsible for 
cleavage of the displaced 5' RNA–DNA flap during Okazaki fragment maturation189.  The 
helicase domain may play a role in unwinding duplex DNA at or near the site of endonuclease 
cleavage190.  
              Dna2p also plays a role in telomere length regulation and virtually all dna2 mutants 
have a slight telomere lengthening phenotype95. Dna2p is a component of telomeric chromatin 
and its localization to telomeres is dynamic, suggesting that it might have a role in telomere 
replication and telomere capping191. Both chromatin immunoprecipitation (ChIP) and 
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immuofluorescence experiments show that Dna2p is preferentially associated with telomeric 
DNA in G1 phase. Because there is no telomere replication at this point in the cell cycle, it has 
been proposed that Dna2p plays a role in capping the chromosome end. Consistent with its role 
in Okazaki fragment replication, Dna2p is redistributed in S phase from the telomeres to sites 
throughout the replicating chromosomes. In late S phase Dna2p returns to telomeres and remains 
there until the following S phase. Furthermore, Dna2p has been shown by de novo telomere 
addition assay to be required for telomerase-dependent telomere replication. Using this assay, 
there is no telomerase-mediated telomere addition in a dna2-2 mutant at restrictive temperature. 
dna2-2 est2Δ or dna2-2 est1Δ strains have an accelerated senescence phenotype compared with 
either single mutant, suggesting that Dna2p and telomerase may cooperate in telomere 
maintenance or stability through different pathways.  Taken together, these results suggest that 
the completion of lagging-strand replication involving Dna2p at telomeres may require tight 
coordination of the lagging-strand replication with telomerase activity.  
This appendix describes experiments to explore generic and physical interactions 
between the lagging strand replication machinery and telomerase Est2p. While suggestive 
genetic interactions are observed, no physical interactions have been detected. 
 
Results 
Genetic Interactions between EST2 and DNA2  
              Considering the slight telomere lengthening effects of dna2 alleles, we reasoned that if 
est2-LT mutants partially affect the same pathway, combining the two mutations might produce a 
synergistic phenotype.  We first created strains that are dna2-1 (a ts mutation in the endonuclease  
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Figure 24. DNA2 affects telomere length and interacts with EST2. 
A. Schematic structure of Dna2p (modified from95). All mutations marked have longer than  
 normal telomeres.  
B. Allele-specific interaction between dna2 alleles and est2-LT N95A or est2-LT E76K. Genomic    
  DNA from wild type (lanes 1, 13) or the indicated mutant strains were digested with XhoI  
 and separated on a 1.2% agarose gel. A 32P labeled telomeric probe was used to detect the  
 telomeres. Color indicates multiple mutations in the same allele. Not all alleles have been  
 completely sequenced 95.  
Note: This experiment was performed by Geoff Todd. 
 125 
Table 7. Genetic interaction between dna2 and est2-LT.  
 
Strains Average Telomere length (bp) Change compared with WT (bp) 
WT 300  
est2-LTN95A 347 47 
dna2-1 369 69 
est2-LTN95A dna2-1 #1 585 285 
est2-LTN95A dna2-1 #2 579 279 
dna2-5 441 141 
est2-LTN95A dna2-5 456 156 
dna2-8 416 116 
est2-LTN95A dna2-8 425 125 
dna2-1 369 69 
est2-LTE76K 395 95 
est2-LTE76K dna2-1 741 441 
Telomere length calculation from the gel shown in Figure 24. A standard curve was generated 
from the molecule mobilities. The median of the telomere smear of each sample was estimated 
by eye and the size in base pair was calculated using the standard curve. 
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Figure 25. Allele-specific interactions between plasmid-borne dna2 and est2-LTE76K  
A. Genomic DNA from the indicated strains was digested with XhoI and separated on a 
1.2% agarose gel. A 32P-labeled telomeric probe was used to detect the telomeres.  
      Note: This experiment was performed by Stan Sonu.  
B. Summary of genetic interactions between DNA2 and est2-LTE76K.  A schematic of DNA2     
 functional domains is shown.  Mutations below the line cause a synergistic phenotype in  
 combination with est2-LTE76K. Color indicates multiple mutations in the same allele. Not  
 all alleles have been completely sequenced 95. 
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domain of DNA2) est2-LTN95A or dna2-1 est2-LTE76K. est2-LTN95A causes telomere over-extension 
by ~50bp, and dna2-1 cause telomere over-extension by ~70bp, so if the effect is additive, we 
would expect a telomere lengthening of ~120bp in the double mutant. Strikingly, the telomere 
length of the double mutant is ~280bp longer than that of wild-type (Figure 24B, Table 7), 
suggesting a synergistic effect.  This phenotype is even more pronounced in dna2-1 est2-LTE76K,  
which has ~440bp over-extension effect instead of the ~170bp predicted by additivity.  For two 
other temperature sensitive mutations in DNA2, dna2-5 and dna2-8, the length of the double 
mutants is only slightly longer than either single mutant (Figure 24B, compare lane 5 with 6, lane 
7 with 8), suggesting that the interaction between EST2 and DNA2 is allele-specific.  
 To test the extent of this allele-specificity, a genetic system was set up to create double 
mutants by sporulation and dissection. An est2-LTE76K/est2-LTE76K DNA2/DNA2 diploid was 
created by transient expression of HO endonuclease in a MATa est2-LTE76K strain. Because 
DNA2 is essential for cell viability, one copy of DNA2 was replaced by the KanMX gene in this 
diploid by one-step gene replacement.  Individual plasmids containing 17 sequenced dna2 alleles 
(gift of T. Formosa) were transformed into the est2-LTE76K/est2-LTE76K DNA2/dna2::KanR strain. 
The resulting diploids were sporulated and dissected to obtain haploid est2-LTE76K dna2::KanR 
strains expressing a dna2 allele on a LEU2 plasmid. The dna2 single mutants was generated in a 
similar manner by creating an EST2/EST2 DNA2/dna2::KanR diploid and transforming with dna2 
alleles as described above. These experiments were conducted separately because of the 
difficulty in screening rapidly for presence of the est2-LTE76K mutation in the haploid spores. 
Telomere length of the double mutants was assayed by Southern Blot and compared with that of 
either single mutant. The est2-LTE76K dna2::KanR  pdna2-1 strain show less telomere lengthening 
than est2-LTE76K dna2-1 (compare lane 12 in Figure 24B with lane 1 in Figure 25A) in which the 
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mutation is integrated into the chromosomal DNA2 locus. This result likely reflects suppression 
of the dna2-1 defect due to maintenance of more than one copy of plasmid in one cell. 
Preliminarily we found that dna2-4, dna2-14 show possible synergistic interactions with est2-
LTE76K. To confirm this result, these mutations will be integrated into the genome.  
 
Genetic interaction between est2-LT and other lagging stand mutants 
Many strains containing mutations in components of the lagging strand replication 
machinery have longer than normal telomeres, the mechanism of which is unclear. It is 
hypothesized that these mutants are defective in lagging strand synthesis, which disrupts Rap1p’s 
association with telomeres and results in telomere lengthening, suggesting a general mechanism 
in all such mutants. Given the allele-specific interaction between DNA2 and EST2, I set out to 
examine whether other mutations in the lagging strand replication machinery interact geneticall 
with est2-LTE76K.  
An EST2/est2-LTE76K CDC17/cdc17-2 diploid was created and sporulated. Telomere 
length of WT, est2-LTE76K, cdc17-2 and est2-LTE76K cdc17-2 strains was assayed by Southern 
Blotting. As shown in Figure 26A, there is additive telomere lengthening in the double mutant 
compared with each single mutant, suggesting that est2-LTE76K and cdc17-2 cause telomere over-
extension through distinct mechanisms. Furthermore, cdc17-2 is not TEL1 dependent (Figure 
26B), supporting that it causes telomere lengthening by a different mechanism than est2-LTE76K. 
This result also suggests that the telomere overlengthening in cdc17-2 is not dependent on Rap1p 
counting. Preliminary data suggests that other long telomere mutants in lagging strand 
replication machinery (rad27Δ, pol12-216) do not interact with est2-LTE76K either (data not 
shown). 
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Figure 26. Genetic interaction between CDC17 and EST2. 
A. cdc17-2 is genetically independent of est2-LTE76K. 
 Genomic DNA from indicated strains were digested with XhoI and separated on a 1.2%  
 agarose gel. A 32P labeled telomeric probe was used to detect the telomeres 
B. Telomere lengthening phenotype of cdc17-2 is Tel1p-independent. Southern Blotting was  
 performed as described in A.  
 The length difference between cdc17-2 in A and B is possibly due to different strain  
 background.
 130 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
Figure 27. Physical interactions between Est2p and Dna2p or Pol1p.  
A. There is no detectable interaction between Dna2p-TAP and Myc9-Est2p in asynchronous or   
      nocodazole-blocked cultures.  Protein Extract was made from BY4741 Dna2-TAP Myc9-Est2  
 grown asynchronously (A) or blocked in nocodazole (G2/M) and immunoprecipitation was  
 performed using IgG beads or anti-Myc antibody as indicated.  
B. There is no detectable interaction between Pol1p-HA3 and Myc9-Est2p in asynchronous  
 culture. Protein extract was made from BY4741 Dna2-TAP Myc9-Est2 grown  
 asynchronously or blocked in nocodazole and immunoprecipitation was performed using  
 anti-Myc or anti-HA antibody as indicated. All experiments have been repeated at least  
 twice. 
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Physical interactions between Est2p and components in lagging strand replication 
 Physical Interactions between TERT and other lagging strand replication components 
such as Pol1p have been shown in ciliates and fission yeast. The allele-specific interaction 
between DNA2 and EST2 also suggests a possible physical interaction between Dna2p and Est2p. 
 In order to test whether there are such interactions in S. cerevisiae, 
coimmunoprecipitation between Est2p and Dna2p or Pol1p was performed. Dna2p-TAP was 
immunoprecipitated and probed for Myc9-Est2p. Interactions between Myc9-Est2p and Pol1p-
HA3 was tested in both directions. As shown in Figure 27, there are no detectable interactions 
between Est2p and Dna2p or Pol1p. The interaction between Est2p and Dna2p was examined in 
nocodazole-blocked cells when Dna2 is required for de novo telomere addition and there is no 
detectable interaction either (Figure 27B). It is possible that the interaction between Est2p and 
Dna2p or Pol1p is transient in vivo, so in vivo crosslinking by DSP was performed to stabilize 
any interaction.  CoIP after DSP treatment did not detect any interaction between Est2p and 
Dna2p (data not shown).  Northern blotting was used to examine if there is any interaction 
between telomerase TLC1 RNA and components in lagging strand replication including Dna2p, 
Pol1p and Pol12p. Strains expressing TAP-tagged alleles of each of these genes were obtained 
from a strain collection (Open Biosystems, AL). An Auxilin-like protein involved in vesicular 
transport (Swa2p) and a protein component of the H/ACA snoRNP pseudouridylase complex 
(Gar1p) were used as negative controls and Est2p-TAP was used as a positive control. As shown 
in Figure 28, because some residual association of TLC1 can be detected with Swa2p and Gar1p, 
it is unclear whether the weak association of TLC1 with Pol1p and Pol12p is significant. Binding 
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Figure 28. Pol1p, Pol12p and Dna2p do not reproducibly interact with TLC1 RNA.  
Protein extracts were immunoprecipitated with IgG beads as previously described. RNA was 
isolated from 10ul protein extract or immunoprecipitation beads and detected by Northern 
Blotting as described. Hybridization was performed simultaneously with probes specific for 
random primed 32p-TLC1 RNA and 32p-labeled U1 snRNA.  
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to Dna2p was not detected. RT-PCR was also attempted but failed because of non-specific 
amplification in non-tagged strain (data not shown). 
 A corresponding mutation in S. pombe trt1E98K causes telomere lengthening (as shown in 
Chapter III). Since the interaction between Pol1p and Trt1p was previously demonstrated, it 
provided an opportunity to explore whether this interaction might be disturbed by E98K 
mutation. Coimmunoprecipitation experiments were performed to detect the interaction between 
Pol1p-Flag and plasmid-born Trt1p-Myc or Trt1pE98K-Myc. Consistent with previous 
publications Pol1p interacts with Trt1p in vivo. Because the results were complex and E98K and 
E101K mutations seem to alter the interaction in a similar manner that is not related to telomere 
lengthening, they have not been further pursued (data not shown).  
 
Discussion 
 In this part of my thesis, I examined possible interactions between Est2p and 
proteins of the lagging strand replication machinery. Although we have detected allele-
specific genetic interactions between dna2 and est2-LT, I was unable to detect any physical 
interaction between Dna2p and Est2p. Therefore, the mechanism of this genetic interaction 
remains unclear.  
 Clustering of the mutations that act synergistically with est2-LTE76K (Figure 22B) in 
the primary sequence of DNA2 is intriguing and strongly suggests a functional interaction 
between these proteins. It is possible that these two proteins affect telomere length through 
the same pathway without direct protein-protein interaction. With a list of new phenotypes 
identified in est2-LT by telomere sequence analysis, ChIP, telomeric silencing, we can test 
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whether similar alterations in the dna2 alleles that genetically interact with est2-LTE76K can 
be observed.  
 Meanwhile, the specificity of the genetic interaction between dna2 and est2 can be 
tested in the est2 direction (est2-LT, est2-motifE and est2-up34) discussed in previous 
chapters). Since all these long telomere mutants have similar sequence change, I proposed 
in Chapter III that the telomere sequence change in these mutants might be a consequence, 
rather than a cause of telomere lengthening. Elucidating the specificity of est2-dna2 genetic 
interaction will further test this hypothesis.  
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Materials and Methods 
 Yeast strains used are listed in Table 8. One copy of the DNA2 gene in diploid 
strains DKF206 and DKF207 (Table 4) was replaced with KanR by PCR product from 
primers: 5’-TTTGTGCAAGCAAACACTGACAATTGAAGAGATCGTCAGGCGGAT 
CCCCGGGTTAATTAA-3’ and 5’-TAGCTTTCCTGTTATGGAGAAGCTCTTCTTATT 
CCCCCTGGAATTCGAGCTCGTTTAAAC-3’ using pFA6a-KanMX6 to create Strain 
DKF209 and DKF210. pTF098 (DNA2 LEU2 CEN), pTF098-1 (dna2-1 LEU2 CEN), 
pTF098-3 to pTF098-17(dna2-3 LEU2 CEN to dna2-17 LEU2 CEN), pTF098-19 (dna2-19 
LEU2 CEN), and pTF098-23 (dna2-23 LEU2 CEN) were transformed into DKF209 and 
DKF210 and the diploids were sporulated and dissected. DNA2:: KanR  pTF098-X and est2-
LTE76K DNA2:: KanR  pTF098-X were selected on YPD+Geneticin and SD-LEU plates. 
 Plasmids pTF098-1, pTF098-3 to pTF098-17, pTF098-19 and pTF098-23 were 
obtained from T. Formosa. pTF098-1 was made by ligating SacII-XmaI fragment from 
PCR product using genomic DNA from dna2-1 strain as template into the SacII-XmaI 
vector fragment of pTF098.   
 Plasmid pRS304+Myc9+EST2 bearing a Myc9 epitope tag at the N-terminus of 
EST2 was digested with HpaI and integrated into YKF250 (BY4741 Dna2-TAP) to create 
strain YKF251. 
 PCR product from Primers 5’-CTACGTTGATATGACTAGCATATTTGATTTC 
ATGCTAAATCGGATCCCCGGGTTAATTAA-3’ and 5’-GAATATTCATGAGATCAC 
ACAACACATACAAAATACTTACGAATTTCGAGCTCGTTTAAAC-3’ using pFA6a-
3HA-KanMX6 as template was used to integrate an HA3 epitope tag at the N-terminus of 
Pol1p (YKF252).  
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 Southern Blotting and Western blotting were performed as previously described in 
Chapter IV. Northern Blotting was performed as described in49. Protein extracts were 
immunoprecipitated using IgG beads.  
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Table 8. Strains used in the Appendix. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Strain Genotype Source 
DKF209 MATa/MATa trp1/trp1 leu2/leu2 ura3/ura3 his7/his7 DNA2/dna2∆:: KanR This thesis 
DKF210 MATa/MATa trp1/trp1 leu2/leu2 ura3/ura3 his7/his7 est2-LTE76K/est2-LTE76K dna2∆:: KanR This thesis 
DKF211 MATa/MATa trp1/trp1 leu2/leu2 ura3/ura3 his7/his7 DNA2/dna2∆:: KanR  pTF098 This thesis 
DKF212 MATa/MATa trp1/trp1 leu2/leu2 ura3/ura3 his7/his7 est2-LTE76K/est2-LTE76K dna2∆:: KanR 
pTF098 
This thesis 
YKF250 BY4741; MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 DNA2-TAP Open 
Biosystems 
YKF251 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 DNA2-TAP Myc9-EST2 This thesis 
YKF305 MATa leu2 trp1 ura3-52 prb1 prc1 pep4-3 Myc9-EST2 49 
YKF252 MATa leu2 trp1 ura3-52 prb1 prc1 pep4-3 Myc9-EST2 HA3-POL1 This thesis 
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